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Two Methodologies in Pursuit of the Elucidation of Copper (II)—Centered
Bioinorganic Chemistry

William John Wagner

ABSTRACT

Copper is a widely distributed transition metal in the earth’s crust and
has been adopted in a variety of biological systems. In many ways the
biochemical usefulness of copper stems from its positive redox potential. This
positive redox potential allows copper to assist in the movement of electrons.
Copper ions can be found in natural systems as either CuI, CuII, or CuIII in
part due to this redox potential. While CuII -centered biochemistry has been
studied for years, mechanistic details in certain CuII -centered redox
reactions remain unresolved. This thesis presents two methodologies for
studying natural systems with known CuII -centered redox capabilities in
order to better elucidate the mechanistic intricacies of copper ion chemistry.
The first method explored involves the promiscuous enzyme Streptomyces
griseus aminopeptidase (SgAP) which although known primarily as a
peptidase has been shown to oxidize catechol under near physiological
conditions in vitro when its native ZnII ions are replaced by CuII ions. Protein
ix

engineering techniques were utilized toward expression a functional
recombinant enzyme in wild type and mutant forms. The goal was to utilize
site directed mutagenesis of residues in the active site to determine which
residues are involved in both the hydrolysis and/or the oxidative activities of
SgAP. The second methodology explored was the use of the N-terminus of
Histatin-5, a naturally occurring peptide that is known to form complexes
with CuII, as a model system to study CuII -centered oxidation chemistry.
Metal-Peptide complexes are much more simplified systems which use the
same building blocks as proteins, but reduce the structure to the minimal
functional unit necessary for activity. This in turn, simplifies the study of
their catalytic chemistry as influences outside of the active region are greatly
reduced. Furthermore, chemical synthesis of short peptides is easily
performed and inexpensive in comparison to protein engineering, thus
enabling further exploration, if deemed necessary, to be a feasible and
economically viable possibility.

x

Chapter I:

INTRODUCTION TO STREPTOMYCES GRISEUS
AMINOPEPTIDASE

1.1

Hydrolysis
Hydrolysis is a type of chemical reaction that breaks a bond by adding

water through the activation of water to generate a powerful hydroxide
nucleophile. This reaction is the primary mechanism for catabolism in cells
and is able to break down all classes of macromolecules in the cell. Although
hydrolysis can occur spontaneously, it is not particularly favorable, resulting
in macromolecules being rather stable at physiological pH. Thus, the
degradation of macromolecules requires enzymatic catalysis to proceed at a
rate suitable for the metabolic functions of the cell. Generally, the
breakdown of macromolecules is highly specific, with different classes of
enzymes carrying out the degradation of different classes of macromolecules.
The three-dimensional structure of the macromolecules and the geometry of
the bonds that hold them together determine the structure and amino acid
composition of the catalytic site of the enzyme responsible for degrading
each macromolecule. Although variations occur within each class of enzyme,
the structural constraints placed upon these enzymes by their substrates lead
to similarities within each class. Herein, the hydrolysis of two types of
macromolecules, peptides and ester-linked molecules, is discussed, which is

1

followed by a description of an enzyme that, although known primarily as a
peptidase, also has the ability to hydrolyze ester linkages.
1.2

Hydrolysis of Esters
Esters are an important target for hydrolysis in biological systems.

Ester bonds can be found in energy storage uses (i.e. ester linkages of
triglycerides in fats). Their presence in carbohydrates means they also
contribute to structural integrity of plant cell walls1 and also the exoskeleton
of insects.2 Esters are also found as the backbone of nucleic acids in the
form of phosphodiesters as well as the short term energy carrier ATP. While
the reaction mechanisms of peptide and ester hydrolysis are similar, there
are key differences in phosphoester hydrolysis. In traditional esters the
nucleophilic water attacks from the top or bottom of the carbonyl plane. In
phosphoester hydrolysis, the hydroxide attacks in an “in-line” SN2-like
manner attacking the carbonyl carbon from the side directly opposite the
leaving group. This SN2-like attack leads to a tetrahedral transition state in
carbonyl esters (RCOOR’) but a trigonal bipyramidal transition state in
phosphoesters.
1.3

Hydrolysis of Peptides
Peptide bond cleavage in biological systems is a function performed

by enzymes called peptidases. Peptidases come in three general classes:
metal-dependent, serine, and cysteine proteases. The significant role of
peptide bond hydrolysis in biology cannot be overstated due to its
involvement in digestion of peptides, regulation of hormones, and the
2

Figure 1-1: Mechanism of Ester Hydrolysis

3

maturation process of some proteins.3–5 In the absence of enzymatic
assistance, the amide bond is particularly stable to all but the most extreme
pH and temperature conditions.6 The mechanism for the hydrolysis of
peptide bonds at alkaline pH is well established. The hydroxide nucleophile
attacks the carbonyl carbon from the top (or the bottom) of the plane of the
peptide bond to form a tetrahedral transition state typical of peptide
hydrolysis.7 This transition state is followed by the breaking of the peptide
bond into an amine and a carboxylate ion. Acid-catalyzed hydrolysis of the
amide bond is slightly more complicated.8 The reaction begins with the
protonation of the carbonyl oxygen followed by the attack of a water
molecules to form the tetrahedral transition state. The nitrogen is then
protonated by another hydronium ion. The acid is reformed when one
oxygen atom is stripped of its proton to initiate lose of the transition state
that ends with the amine being kicked off the carbon, resulting in a
carboxylic acid and an amine.
In addition to the three major types of peptidases, there are various
minor ones as well (namely Threonine, Aspartic acid and glutamic acid). The
classifications for peptidases are based on what is most responsible for its
catalytic activity. For instance, serine peptidases use the deprotonated side
chain of a serine residue to act as the nucleophile for amide bond cleavage
(as opposed to the hydroxide anion discussed in the preceding section).
There are at least two essential parts to any peptidase. First, it must have
the substrate binding/recognition site. Secondly, it must have a catalytic
site. Furthermore, peptidase may be classified as either exo- or
4

Figure 1-2: The mechanism of peptide hydrolysis.

5

endopeptidases, depending on whether the enzyme cleaves the protein in the
middle (endo) or at the end (exo) of the polypeptide.
1.4

Serine Peptidases
One of the most well studied serine peptidases is trypsin. Trypsin is

one of the many enzymes used in the digestive system of animals to
breakdown peptide bonds. Furthermore, it gained widespread use in the
biological fields in the determination of amino acid sequences in proteins (i.e.
the Sanger Method) due to its specificity for Lys and Arg residues. The
general mechanism for serine proteases starts with a His in the active site
acting as a general base to form an hydrogen bond with the serine. This
activates the serine to attack the amide bond in a similar fashion described
for peptide hydrolysis under basic conditions. The protonation of the
nitrogen in the transition state is carried out by the same His, which now is
acting as a general acid. After the hydrolysis of the peptide bond, the amine
is free to disassociate, but the carboxylic acid terminus of the amino terminal
fragment of the substrate is covalently bound to Ser-195. Water is then
activated by His to form hydroxide anion, which attacks the covalent
intermediate, leading to another tetrahedral transition state. This results in
the release of the amino terminal fragment and the regeneration of the
active site of the enzyme for another catalysis.9
1.5

Cysteine Peptidases
Cysteine peptidases function in a very similar way to serine

peptidases. The main exception is that cysteine rather than serine acts as
6

Figure 1-3: Catalytic mechanism of the serine peptidase Trypsin.

7

the initial nucleophile by attacking the carbonyl carbon. Various other amino
acids within the active site play supporting roles, depending on the particular
enzyme. For example, papain uses Asn-175 to activate His-159 (rather than
Asp as in Trypsin) which can then donate a proton to the nitrogen of the
peptide bond. This, of course, is a necessary step in peptide bond hydrolysis.
Papain also utilizes Gln-19 as well as the nitrogen of Cys-25 to stabilize the
carbonyl of the target peptide.10
1.6

Metallopeptidases
Metallopeptidases are the most diverse group of peptidases due to two

important factors. First, a variety of metal components can be present. For
instance, the peptidase may contain zinc, iron, or manganese in the active
site. Second, a varying number of metal components present can complicate
the catalytic mechanism. Generally speaking, the most common
metallopeptidases have either one or two metals in their catalytic centers;
however, trinuclear metal centers do exist. Moreover, the metal components
need not be homogenous, but heterogeneous metal centers do exist as well.
1.7

Angiotensin Converting Enzyme (ACE): a mononuclear zinc containing
peptidase
ACE is one of the most interesting mononuclear zinc peptidases. In

mammals this enzyme is responsible for at least two extremely important
functions: the conversion of angiotensin I to angiotensin II (a potent
vasopressor) and the breakdown as well as inactivation of the important
vasodilator bradykinin.11 The overall result of the action of this peptidase is
8

Figure 1-4: The catalytic mechanism of the cysteine peptidase
Papain.

9

to raise blood pressure.

Due to the potent hypertensive effect of ACE, it

has become the main target in anti-hypertension treatment. The drug class
known as ACE inhibitors has become the first line of treatment not only for
hypertension but also congestive heart failure and diabetes related and nondiabetes related nephropathy. A noteworthy feature of ACE homologues is
their ubiquitous nature. Homologues of ACE can be found in organisms that
lack both angiotensin and a cardiovascular system.12
ACE was first discovered in equine plasma samples; however, it is now
known to be membrane bound, with highest concentrations in the epithelial
cells of highly perfused tissues such as the kidney and lungs.12

In

mammals, there are two forms of ACE. The somatic form, sACE, is
ubiquitously distributed around several types of tissue and consists of two
transmembrane, a large cytosolic, and an N- and C-terminal extracellular
domains. The extracellular domains are similar, but each contains a different
active site configuration and different substrate preferences12. The other
form found in mammals is the germinal or testicular ACE (gACE or tACE).
gACE is 701 amino acids long and is identical to the C-terminal of sACE aside
from the first 36 amino acids.11

Whereas the function of sACE is well

established, the function of gACE is still unknown. However, knockout mice
studies have shown that deletion of gACE gene leads to greatly decreased
fertility.12
Unfortunately, there have been insurmountable difficulties with
purification and subsequent crystallization of sACE. One of the main reasons
10

is that ACE is heavily glycosylated, which leads to microheterogeneity of the
oligosaccharides on the surface, preventing the ordered packing necessary
for crystallization.11 Despite these difficulties, gACE was finally crystallized
as well as the Drosophilia homologue, AnCE.
The similarities both in sequence and crystal structure between the
active sites of another peptidase, thermolysin, and ACE suggest a similarity
in mechanism.11 The accepted mechanism for thermolysin was proposed by
Brian Matthews in 1988.13 The key feature is the zinc binding motif (HEXXH)
in which the two active site His residues coordinate to the zinc ion. There is
also a Glu and a water molecule which complete the tetrahedral ligand field
for the zinc.12 According to Matthews,13 the zinc cation fulfills an important
role in the catalysis of peptide hydrolysis. First, it binds the carbonyl of the
target amide bond; this attack on the carbonyl carbon makes the resulting
product more energetically favorable by balancing the oxygen anion. The
zinc also helps to activate the coordinated water molecule to form hydroxide
and initiates the attack. The active site then donates the proton to the
amine group of the peptide bond.13 This stabilizes the amine group and by
giving it a positive charge encourages the electron cascade from the carbonyl
oxygen.
The crystalographic study by Gordon et al.14 revealed other interesting
aspects of this ACE. The study shows why ACE preferentially digests small
unfolded peptides over larger folded proteins. The crystal structure contains
a deep cleft that extends 30 Å into the interior of the globular protein, which
11

Figure 1-5: Comparison of the crystal structures of the active sites of
thermolysin and tACE.

12

is guarded by several charged residues at the clefts opening. This cleft
restricts the types of substrates that can possibly come in contact with the
active site. The study also revealed significant structural homology between
tACE, AnCE, and neurolysin despite their low sequence homology.11
This interesting situation where there is significant structural homology
without sequence homology reveals a phenomenon of biology. Nature
follows the rules set forth by physical laws. In order to facilitate the breaking
of the surprisingly strong peptide bond, an enzyme must have both the
correct three-dimensional structure to interact with the peptide bond and the
appropriate amino acid side chains in the active site positioned in such a way
that they facilitate the movement of atoms and/or electrons required for
catalysis. As such, it frequently occurs that enzymes that perform similar
tasks have similar three dimensional structures. There are two possible
theories as for how these enzymes come to resemble each other so
strikingly. First, proteins encoded by genes that all arose from the same
ancestral gene, which have undergone only conservative mutations, will
result in a structure that remains largely unchanged, even though the actual
sequence can differ to varying degrees. This is termed divergent evolution.
Alternatively, the particular structure could have evolved multiple times from
different gene lineages. This convergent evolution postulates that earlier
structures that did not resemble each other eventually evolved to form a
three dimensional shape that bears a strong resemblance to each other. The
evolutionary history of genes that encode proteins with similar functions can
easily be determined using bioinformatics tools for phylogenetic analysis.
13

The important thing, however, is that it is through these relationships a study
about one enzyme in a class can be inferred to another enzyme within its
class. It is known that certain sequences, such as the HEXXH motif,13 occur
often and perform similar functions in different enzymes, and through this a
starting point for future research on new enzymes can be found. This
inference system is often used to propose mechanisms of enzymes that have
yet to be thoroughly studied by comparing their structural homology (or
sequence homology) to well-studied enzymes
1.8

Aeromonas proteolytica aminopeptidase (AAP): a di-zinc
aminopeptidase
Di-zinc aminopeptidases similar to AAP have been implicated in many

disease states. Many drugs used in the treatment of cancer and HIV can be
linked to their effect on dinuclear metallopeptidases15- 20. The similarities
among peptidases of this class enable the inference of mechanisms relevant
to all members from studies on particular model proteins. As such, studying
a similar di-zinc aminopeptidase from Aeromonas proteolytica and how
inhibitors interact with it can serve as a model and lead to the design of new
drugs with greater efficacy.
Sequence and structural studies of AAP have revealed that there is a
small hydrophobic pocket which is just large enough to support the Nterminal amino acid. This explains why AAP is an aminopeptidase and not an
endopeptidase. Inhibitor studies support the preference for hydrophobic
residues in that alcohols with longer carbon chains and more steric hindrance
14

decreased the Ki from 860 mM with methanol to 0.98 mM with 3-methyl-1butanol.21 As is usual for peptidases, the tetrahedral transition state analogs
are known inhibitors of AAP. These inhibitors mimic the transition state of
peptide hydrolysis and so are thought to compete for the active site. Metal
chelating agents are also inhibitors of AAP by sequestering the metal ions
necessary for catalysis21.
Through the inhibition as well as structural studies, the mechanism for
AAP has been elucidated. The zinc ions are in similar coordination spheres,
both having one His residue directly coordinated to the zinc ion, a bridging
water, and a bridging Asp. Zn1 is coordinated to a Glu, while Zn2 is
coordinated to an Asp. This gives a distorted tetrahedral coordination sphere
to each Zn ion.21 Upon substrate binding to the hydrophobic pocket, the
bridging Asp coordination is replaced (on Zn1) by the carbonyl oxygen of the
amide bond. Water is then deprotonated by Glu-151 to form hydroxide,
which attacks the carbonyl carbon. The Zn1-carbonyl oxygen interaction
stabilizes the tetrahedral transition state that came about by the hydroxide
attack on the carbonyl carbon. The proton gained by the Glu from the
activation of water to hydroxide is transferred to the nitrogen of the amide
bond along with the breaking of the amide bond and the release of the
second amino acid. The carbon to oxygen double bond then reforms as the
oxygen dissociates from Zn1 and is replaced by the original bridging Asp.
Other interesting studies from AAP involved the manipulation of the
metal centers. By removing the metals from the enzyme and then
15

Figure 1-6: The active site structure of Aeromonas proteolytica
aminopeptidase.

16

Figure 1-7: The mechanism of peptide hydrolysis of the di-zinc
metallopeptidase Aeromonas proteolytica aminopeptidase.21
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reconstituting with two equivalents of another transition metal (copper,
cobalt, or nickel) the activity is altered (some greatly increased activity while
others reduced it).22 Addition of one equivalent of a different transition metal
to the apo-AAP followed by an equivalent of ZnII dramatically increases the
activity as well as changes the binding affinity (KM).22
Although not medically relevant in any direct manner, the fact that
nature has evolved only a few ways to perform peptide hydrolysis with a dinuclear center provides ample reason to study AAP. The study of AAP over
the medicinally relevant enzymes is preferred due to the simplicity of
purification from natural sources. Furthermore, the growth of bacteria is
generally easier, and purification from bacteria is simpler. As such, using
bacteria as expression systems is preferable over eukaryotic cells. Further
complicating matters, acquiring recombinant proteins using DNA from a
eukaryotic source contains many more hurdles than using a prokaryotic
source. Controlling of the expression of eukaryotic genes is more complex
than bacterial genes, since the eukaryotic DNA is more complicated than
bacterial DNA with the presence of introns and exons, necessitating posttranscriptional modification (a problem overcome by using reverse
transcriptase and processed mRNA). Another complication in trying to
express a eukaryotic gene in bacteria, even after removing the exons, is the
great differences in codon usage frequencies between species that diverged
so long ago. This results in some codons calling for tRNAs that are available
in abundance in the original eukaryote that simply do not exist in bacteria.

18

Thus, the translation is interrupted, resulting in a truncated and useless
protein.
1.9

Streptomyces griseus aminopeptidase (SgAP)
The aminopeptidase from the culture medium of Streptomyces griseus

is a single peptide chain with 284 residues (from the protein data bank) and
a molecular weight of approximately 30kDa.23 Native SgAP contains two ZnII
ions and requires both for peptidase activity.24 There is also a calcium cation
that enhances activity of native SgAP, but due to the great distance between
the calcium binding site and the catalytic center (25 Å) the mechanism of this
activation remains unknown. The substrate preference for SgAP is for large
hydrophobic amino terminus residues24 preferably leucine25 and is maximally
active at pH 8.0.26 The ligand environment for the first ZnII, based on x-ray
crystallography studies, is proposed to be His-85, Asp-160, and a bridging
Asp-97 and bridging dibasic phosphate. The ligand environment for the
second Zn2+ is His-247 and Glu-132 as well as the bridging Asp and dibasic
phosphate.27 More recently, however, NMR studies suggest that the bridging
phosphate is a product of the crystallization medium and is not bound to the
active site in solution. Instead, a water molecule or a hydroxide is proposed
to replace the phosphate in the active site.26 This active site is quite similar
to that of other aminopeptidases such as Aeromonas AP which was described
previously. The incredibly similar active site structures between AAP and
SgAP suggest a similar mechanism for peptide hydrolysis, however key
differences have been discovered (most notably those revealed by metal
19

titration and inhibitor studies). The Active site of AAP and SgAP are
compared in Figure 1-1. Metal titration studies to SgAP have demonstrated
that the two metal sites are not identical and that binding happens
sequentially. This is particularly noticeable when CoII is used as the titrant in
the absence of calcium at pH 6. Furthermore, these studies have shown that
SgAP requires both metals for activity, as detectable activity is shown only
when greater than one equivalent of CoII has been added.

There is a sharp

rise in activity between 1 and 2 equivalents with an activity plateau forming
shortly after 2 equivalents have been added to solution.25
Although cobalt is not the native metal for SgAP, it is used because of
its sequential binding, in the absence of calcium. It should be noted,
however, that sequential binding takes place with zinc as well. It is,
however, not as well pronounced.25
Given the similarities between AAP and SgAP it is difficult to see why
one would want to study SgAP. There is, however, something peculiar about
SgAP that sets it apart from most aminopeptidases. The unique aspect of
SgAP is that it is able to take a transition state analogue inhibitor like bis-pnitrophenylphosphate (BNPP) and catalytically hydrolyze it. BNPP has
become the standard for colorimetric assays of phosphoesterase activity.28
That SgAP is able to hydrolyze both peptide bonds ane phosphoesters is a
property entitled catalytic promiscuity. Thus SgAP falls into an exclusive
class of enzymes that seem to defy the fundamental dogma of enzymology.

20

Figure 1-8: Comparison of di-zinc aminopeptidase metal centers.
Side by side comparison of the active sites of AAP (Right) and SgAP (Left).
Clearly the ligand environments are very comparable. One difference that is
noteworthy is the inclusion of phosphate in the picture of the SgAP active
site. However, this is not seen in solution phase, but rather an artifact of the
crystallization medium used to determine the active site composition. In
solution, a bridging hydroxyl or water is proposed (as is seen in AAP).

21

1.10

Catalytic Promiscuity and its relationship to evolution
Central to the dogma of enzymology is that enzymes have evolved to

catalyze a particular reaction, generally showing a strong preference for an
exceptionally small range of substrates. This was termed specificity. Over
the years, researchers have stumbled across many examples where not only
did an enzyme catalyze a different type of substrate in the same class of
reaction (hydrolysis of peptide bonds and hydrolysis of ester bonds, for
example) but although considerably more rare, can also catalyze different
types of reactions (hydrolysis and oxidation).
There are various classes of “catalytic promiscuity”. The most
common class is functional group analogues where the bonds broken differ
but the mechanism is likely the same. This is common, for example, in a
peptidase that also hydrolyzes esters.29 Another class involves the change in
mechanism. A mutation in the enzyme that decreases reaction rate but does
not eliminate function must follow a less efficient path and therefore a
different mechanism.29 An example of this is observed in a protein-tyrosine
phosphatase,30 in which the catalytically important Cys was converted to Asp.
This mutant retains some activity, and since the catalytic functional group
was changed, the observed activity must be resulted via a different
mechanism.29 Another class involves a change in substrate specificity.
Changing the substrate specificity leads to slight changes in the transition
state and can be considered as a promiscuous function.29

22

Merely being catalytically promiscuous is not uncommon. The rate at
which SgAP hydrolyzes BNPP is exceptionally high: 4x 1010 greater than the
auto-hydrolysis of BNPP31 and this is very unusual. Whereas most
promiscuous activities show a rate that is a fraction of the native activity,
SgAP activity towards 1 mM BNPP is 33.7 nmol min—1 mg—1 versus SgAP’s
activity to 1 mM Gly-pNA of 19.3 nmol min—1 mg—1.32 Furthermore, the
activity of SgAP on BNPP surpasses that of several natural alkaline
phosphatases: those from chicken intestine and Escherichia coli are 16.5 and
11.1 nmol min—1 mg—1, respectively.28 While there is a great deal of
difference between the hydrolysis of peptides and the hydrolysis of
phosphoesters, most notably in transition state geometry, in essence they
are both hydrolysis reactions. The promiscuity of SgAP extends beyond mere
hydrolysis of phosphoesters. More interesting is the catechol oxidase
activity. Da Silva and Ming33 showed that SgAP was able to catalyze the
oxidation of 3,5-di-tert-butylcatechol (DTC). This oxidation was
accomplished with the di-substituted Cu,Cu-SgAP, by contrast the natural
state of SgAP is Zn,Zn-SgAP. The enzymatic parameters given were kcat=
1.45 s—1 and KM= 0.44 mM and kcat/KM 3295 M—1 s—1. Which is comparable to
a natural catechol oxidase from gypsywort ( kcat/KM 32 mM—1 s—1).33
There is a large body of evidence that supports the claim that these
three activities are catalyzed in the same active site.32 First, dizinc
aminopeptidase inhibitors bestatin, 1-aminobutylphosphonate and Leuhydroxamate inhibit both hydrolytic activities and the oxidative activity.32,33
Second, BNPP is shown to be a competitive inhibitor toward Leu-pNA
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hydrolysis.32 Finally, the activity of BNPP hydrolysis follows that of Leu-pNA
hydrolysis on cobalt titration studies.32 Relative activity versus copper ion
titration revealed very similar patterns for both Leu-pNA hydrolysis and DTC
oxidation (Figure 1-2).

This indicates that as the active site that hydrolyses

peptide bonds is completed by sequential addition of metals, so is the active
site that hydrolyses BNPP, as is the active site for the oxidation of DTC and
as such must be the same site.
There are two groups of scientists that have an interest in catalytic
promiscuity: organic chemists and evolutionary biologists. The reasons for
their interest are usually quite different, and as such what they qualify as
being significant is different. Organic chemists are most interested in
catalytic promiscuity because they have recently discovered the ability of
enzymes to produce stereo-selective products using a broad range of
synthetically useful molecules. Furthermore, the idea that small changes can
be introduced into the enzyme’s primary sequence, which can enable a
promiscuous reaction, can lead to even greater synthetic usefulness for the
chemists. This alternate catalysis of phosphoesters is of interest to chemists
in that the phosphoester is particularly stable. Furthermore, SgAP can
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Figure 1-9: Relative activity of SgAP. DTC oxidation compared to
Leu-pNA hydrolysis by CuII titration to apo-SgAP. Reprinted from
da Silva and Ming.33
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handle high temperatures, withstanding 69 °C for 7 hours and maintaining
approximately 80% activity,32 and so, is an enzyme that has potential for
industrial applications. Evolutionary biologists are more concerned with what
this catalytic promiscuity means for the natural history of this enzyme, or its
family, which can provide a better understanding on how evolution can
happen at a molecular level. Since the two groups have very different
concerns or uses for catalytic promiscuity, their definition of relevance and
focus of study are significantly different. The more discerning of the two
groups is undoubtedly the biologists. They will not be concerned with a
promiscuous reaction that occurs in vitro if it has no biological relevance in
vivo. Biologists have a more pressing reason to be interested with catalytic
promiscuity. Understanding evolution on a molecular level may become
extremely valuable for the agricultural and medical fields. This will aid in
better elucidating the mechanism by which bacteria rapidly evolved to the
pesitices and antibiotics introduced in the 20th century.
There are two informal but important features that are crucial for this
promiscuity. The first is an enzyme’s plasticity, which is its ability to change
the mechanism, binding efficiency, or substrate preference with minimal
changes in the primary sequence. A good example is the muconate
lactonizing enzyme II (MLE). A single amino acid mutation enables MLE to
perform the o-succinylbenzoate synthase activity with high efficiency while
retaining its muconate lactonizing activity.34 Plasticity is a common feature
among enzymes with promiscuous activity. The importance of plasticity in
evolution is evident in the fact that if an enzyme requires a complete
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modification of its primary sequence to change function, random mutation(s)
in the sequence would be insufficient for adapting to new conditions. The
other important feature for an enzyme’s promiscuity is its robustness. This is
a way of stating that an enzyme has the ability to endure mutations with
little impact on its native function and structure. With promiscuous enzymes,
the mutation(s) can result in a drastic increase in the rate of the promiscuous
function, with little change on the rate of the original activity.35 Studies on
robustness have defined an “x factor” as the probability that a particular
protein will be inactivated by a single, random amino acid substitution.36 Low
percentages define the enzyme as being highly robust. Some reported
examples are 3-methyladenine DNA glycolase with x factor value of
34 ± 6%,37 T4 lysozyme ~16%,38 and barnase ~5%.39 These examples show
that robustness can vary widely, but certain proteins can be particularly
robust and thus are stable against random mutations. An enzyme can
display both robustness and plasticity. The reason for this is simple. Not
every amino acid is equivalent; the location in the primary sequence as well
as the nature of the amino acid is important. The nature of the protein as a
whole is also important. If it is mostly hydrophobic residues, the probability
that a mutation will occur at a hydrophobic residue is high. Since the bulk of
the naturally occurring 20 amino acids occurring in proteins are hydrophobic,
a random mutation will probably produce another hydrophobic residue.
Thus, the impact of mutation is minimal. The mutation that gives rise to
plasticity typically occurs at the amino acid(s) near the active site, and the
effect of the change can vary from little to extreme. In a more extreme
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case, a simple change in the primary sequence such as a single amino acid
alteration could result in a drastic change in substrate affinity and specificity
and thus can be labeled promiscuous. If the mutated amino acid is involved
in electron transfer or shuffling, the overall mechanism may be impaired, and
the enzyme may become less efficient or completely lose its function.
An interesting piece of knowledge that has been discovered from the
laboratory studies on directed evolution and promiscuity is that the
mutations that increase promiscuous function with little effect on native
function predominately occur on the outskirts of the active site. In this way
the mutation does not affect the catalytic machinery nor the scaffolding that
holds the catalytic machinery in it’s correct orientation. These mutations
often occur “on surface loops that are part of the substrate binding pocket,
and exhibit high conformational flexibility”.35
Evolutionary biologists should be particularly interested in SgAP in that
this appears to be a snapshot of enzyme evolution. It was discussed earlier
that many enzymes have a plasticity that allows for a very small number of
mutations to result in a drastic change in promiscuous activity.35 While this
has been able to be performed in the laboratory, SgAP appears to be rare in
that it is a naturally occurring acquisition of promiscuous activity. Moreover,
it shows an example of a mutation that occurred without damage to the
native function (i.e. robustness).
An important target for research has been to find what amino acid
residue(s) acts as the molecular switch. That is what residue(s) was
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changed that contributed to the promiscuous function or what may be
changed to further favor one or the other. For the biologist, the molecular
switch in SgAP is important in that it allows one to gain a better idea of how
evolution is working on a molecular level in a natural system. The organic
chemist can learn from the molecular switch by gaining a better
understanding of how one can change other enzymes to enhance their
promiscuous functions for stereoselective synthesis.
Perhaps the most interesting of SgAP’s promiscuity is its catechol
oxidase activity. This is because the hydrolysis of peptides and the
hydrolysis of phosphoesters are essentially very similar (they are both
hydrolytic reactions). That SgAP has evolved, naturally, the ability to
perform redox chemistry, as well as maintain its hydrolytic functionality, is
exceedingly rare and thus warrants special attention. In all fairness, this
redox chemistry is only present when the proper metal substitution has
occurred. It is, however, also fair to point out that copper ions are
ubiquitous in biological systems. Thus, a greater understanding of the
mechanics of copper ions in protein systems is vital.
1.11

Copper Chemistry
The composition of copper in the earth crust is low (approximately

0.7ppm). The rarity of copper combined with its extensive use emphasizes
the importance of its unique properties for biological systems. On the other
hand, a high concentration of copper ions is toxic. This is the result of its
inherent ability to activate molecular oxygen and create destructive reactive
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oxygen species. The biological usefulness of copper ions stems from its high
redox potential, giving copper ions the ability to function as a means of
electron transfer (i.e. plastocyanin and hemocyanin) as well as participating
in many oxidation reactions (i.e. tyrosinase and catechol oxidase).
Therefore, the regulation of copper ions, both in utilizing their redox
properties as well as preventing high concentrations of free ions, is a vital
endeavor of evolutionary processes.
In biological systems, copper-containing enzymes or proteins have
been divided into three classes based upon differences in structural and
spectroscopic characteristics.40 The first class, aptly named Type-1 copper
centers (i.e. in blue copper proteins) are found in electron transfer proteins.
All blue copper proteins have a similar deep blue color which is the result of
Cys S-Cu(II) charge transfer transition with (εmax >2000 M—1 cm—1).41.
Furthermore, the ligand environment for type-1 copper centers is consistent
in that they position the copper into a distorted tetrahedral which is thought
to be the transition state between the favored geometries of CuII (square
planar or tetragonally distorted octahedral) and CuI (tetrahedral).41 One of
the prototypical proteins of this class is plastocyanin. Plastocyanin was
initially discovered by Katoh.42 Early on, its involvement with photosynthesis
was postulated in part due to previous findings by Neish43 and Green,44 which
showed that copper was present in chloroplasts by the inhibition of
photosynthesis when copper ion antagonists were present. Gorman and
Levine46 later showed that the electron transport mechanism proceeded in a
series. The chlorophyll of photosystem II first transfers electrons to
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cytochrome f which then transfers them to plastocyanin and finally the
electrons are transferred to photosystem I. Plastocyanin, as a type-1 copper
center, possesses certain spectroscopic properties, most notably is the
intense absorption band at 600nm (εmax ~5000 M—1 cm—1) giving plastocyanin
its characteristic blue color.46 It is likely that the polypeptide enforces this
ligand environment rather than the metal ion as the metal binding site of
apo-plastocyanin, as well as the HgII-plastocyanin isomorph retains
essentially the same shape as the native CuII-plastocyanin metal binding
site.46 Interestingly, while it is necessary for blue copper proteins to
maintain the distorted tetrahedral shape, slight changes in the axial ligands
are able to fine tune the reduction potentials as well as the reorganization
energy to suit the particular function of their proteins.47 The plastocyanin
from Populus nigra (black poplar), for example, has a redox potential of
370 mV and is thus well suited for transferring between cytochrome f (redox
potential of 340 mV) and P700+( 490 mV). Whereas the blue copper protein
rusticyanin from Thiobacillus ferrooxidans has a redox potential of 680 mV
and would therefore be incapable of shuttling electrons between cytochrome
f and P700+.47 This provides some mechanism in which evolution might
change the polypeptide primary sequence slightly and thus affect its function
either by changing the ligands or even by adjusting the ligands in three
dimensional space to change the degree of distortion in the distorted
tetrahedral. Furthermore, it is likely that this method of fine tuning is likely
to be applied to a greater or lesser degree in the other copper center classes.
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The Type-2 copper centers (i.e. the non-blue copper centers) are
generally oxidases or oxygenases.41 The copper centers in type-2 usually
have three to four ligands and at least one of which is the imidazole of a
histidine49. Cysteine, an amino acid required for type-1 copper centers, is
absent in type-2 copper centers and thus they lack the characteristic blue
color. In contrast to type-1 copper centers which restrict the copper to a
distorted tetrahedral geometry, type-2 copper centers restrict the copper to a
distorted square pyramidal or octahedral geometry46. This, however, is more
of a generalization than a rule in that the geometry of a copper center is
rarely perfectly octahedral, but rather it is often distorted to varying degrees
due to the Jahn-Teller effect. This is the case in CuIIZnII-superoxide
dismutase (CuZn-SOD). CuZn-SOD is one of the well studied type-2 copper
centers. This enzyme catalyzes the disproportionation reaction of superoxide
to hydrogen peroxide and dioxygen:
2O2— + 2H+ Æ O2+ H2O2
Thus, CuZn-SOD enables an organism to deal with the reactive oxygen
species (O2—) that form during cellular respiration and as a result of living in
an oxygen-rich atmosphere. CuZn-SOD catalyzes this reaction in a two step
ping-pong mechanism as such:
(1)

O2—+ CuIIZnSOD Æ O2+ CuIZnSOD

(2)

O2—+ CuIZnSOD + 2H+ Æ H2O2 + CuIIZnSOD

In human CuZn-SOD, the metal-binding environment of copper consists of
four histidines (His 46, His48, His63, and His120) and a water which restrict
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the coordination geometry to a distorted square pyramid.48 The zinc ion is
coordinated by His63 (bridged to the Cu center), His71, His80 and Asp83
which fill its tetrahedral coordination sphere.48 A superoxide anion, which
has previously been nonspecifically protonated, binds the CuII center. The
proton, during the first transition state is exchanged for the CuII by His63.
The superoxide then transfers a single electron to the copper, facilitating the
CuII to CuI transition. At this point the superoxide is oxidized to molecular
oxygen and disassociates. A second nonspecifically protonated superoxide
binds to the CuI center. This time, the CuI transfers an electron to the
superoxide creating a hydroperoxyl anion bound to a CuII. During the second
transition state the proton from His63 is exchanged for CuII while the bond
between CuII and hydrogen peroxide is broken. This is a classic example of a
ping-pong (double displacement) mechanism because one product (O2) is
leaves before the second substrate (HOO•) has bound. Most important is the
substantial change the metal center has undertaken between the first
substrate binding and the second substrate binding, which is accepting an
electron and becoming CuI, providing the driving force for the second
reaction. The mechanism is shown in Figure 1-3. Not all ligands are merely
structural; for example the ligand that bridges the two metal centers (His63)
plays an important role in being a likely source for one of the protons
involved in the superoxide dismutation. Furthermore, the zinc ion likely
makes the Nε2 proton of histidine more acidic, further enhancing the overall
activity.
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Figure 1-10: Mechanism of CuZn-SOD. Adapted from Pelmenschikov and
Siegbahn but printed in Macpherson.48
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The last class of copper centers, type-3, is characterized by a
homonuclear di-copper center. The type-3 copper-containing proteins
generally function as oxidases or oxygenases such as catechol oxidase and
tyrosinase, respectively and in some cases as molecular oxygen carrier
proteins such as hemocyanin.41 Among them, tyrosinase has received
considerable scholarly interests for a variety of reasons including its role in
fruit browning after damage, involvement in disease states (albinism), wound
healing and immune response, and cosmetics (inhibition of tyrosinase in
order to lighten the skin).49 Tyrosinase has both the monooxygenase and
catechol oxidase activity.41 It can accept a substrate with a monophenol
moiety such as the amino acid tyrosine and add a hydroxyl group in the
ortho position to afford a diphenolic compound, catechol. Then, it can further
catalyze the oxidization of catechol to the corresponding ortho-quinone.41 It
is these quinones that are able to spontaneously polymerize to form melanins
as the mechanism to fruit browning.41 Catechol oxidase, by comparison,
lacks the monooxygenase activity and can only catalyze the conversion of
catechol into ortho-quinone.41 The copper atoms in the type-3 center are
antiferromagnetically coupled with a ground state of S = 0 in the presence of
molecular oxygen (in the reduced form) or hydrogen peroxide (in the
oxidized form).41 Upon binding, the di-copper center adopts the oxy-state
with absorbance maxima at 340 nm and 580 nm caused by O2—2 to CuII
charge transfer transition. The deoxy state which contains CuI:CuI is
diamagnetic.43 Both copper sites in the tyrosinase from Streptomyces
castaneoglobisporus crystallized by Matoba et al.51 are each coordinated to
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three histidine residues at the Nε atom. This histidine rich coordination
sphere is a similar feature for all type-3 copper centers including catechol
oxidase and hemocyanin.49

The mechanism by which tyrosinase oxidizes a

monophenol through the catechol-moiety to ortho-quinone is complex, and a
definitive mechanism is still under debate. In one example, the monophenol
binds the oxy-state and is monooxygenated. The catechol-moiety is then
free to disassociate. A catechol-moiety can bind the met-state copper center
and is oxidized to o-quinone, leaving the copper center in the deoxy-state.
The deoxy-state binds molecular oxygen to reestablish the initial oxy-state.41
This mechanism is shown in Figure 1-11. Another proposed mechanism is
similar except that once the monophenol binds the copper center it does not
disassociate until it is o-quinone.49 This mechanism is shown in Figure 1-12.
Given the ability of SgAP to perform catecholase activity it is clear that
it shares more common features with a type-III CuII center. Thus a
comparison of the active sites of tyrosinase and SgAP could provide useful
information in looking for the molecular switch to enhance catecholase
activity (Figure 1-13). An obvious difference is the composition of the active
site. In tyrosinase the ligands are all His residues, while in SgAP a blend of
acidic residues and His residues is present. Thus, potential targets for
enhancing catecholase activity in SgAP would be Asp-97, Asp-160 and Glu132.
In searching for the molecular switch for switching between the
hydrolysis reactions, the most obvious place to start looking was where
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Figure 1-11: Mechanism for tyrosinase. Starting from mono-phenol
moiety through quinone.41 This displays the theory that the intermediate
catechol is released and then subsequently rebound.
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Figure 1-5: Alternative mechanism for tyrosinase. This mechanism
does not allow the relase of the catechol moiety but rather continues through
to the final quinine as championed by Decker et al.49
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Figure 1-13: Comparison of metal centers of SgAP and tyrosinase.
Side by side comparison of SgAP27 (Left) and tyrosinase from Streptomyces
castaneoglobisporus (Right).49
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Harris et al.26 showed a likely phosphate binding moiety. This is because the
alternate substrate, BNPP, has a phosphate and it is the phosphoester that is
cleaved in the promiscuous function. As such, places where phosphate could
bind would make ideal candidates. The NMR studies, as well as phosphate
inhibition studies (showing that phosphate was a noncompetitive inhibitor),
indicated that the most likely candidate would be the Arg residue near the
active site, Arg202.26 Harris was able to use chemical methods to modify the
Arg and found that kcat decreased and the Km increased significantly toward
Leu-pNA. Also the Ki for phosphate inhibition increased as well. These
results indicate that the phosphate and the Leu-pNA interact with the Arg202.26 The chemical modification can be manipulated in such a way to
protect certain Arg residues. By incubating SgAP in a buffer with phosphate
before and during the modification step those Arg that are binding phosphate
should be protected. Following modification the sample with phosphate
protection showed little change in activity, thus Arg-202 when unprotected
was changed and a decrease in activity was seen. Furthermore, protection
with 1-aminobutylphosphonate, which binds at the active site, indicates that
the important Arg is also close to the active site, and the best candidate is
Arg202. The problem with using chemical methods to modify an amino acid
is that it is difficult to be selective. It is usually impossible to modify a single
amino acid, especially in a protein with as many residues as SgAP. As such,
the possibility that an amino acid, similar but separate, to the intended
target was modified and it is this change that is responsible for observed
results (in SgAP there are 8 arginine residues that could be changed). For
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this reason molecular biology has been employed in this research dilemma.
Through site-directed mutagenesis biologists are able to change one amino
acid to another, delete an amino acid or add an amino acid at the DNA level.
This, unlike chemical modifications, is absolutely specific leading to a change
only as specified. The goal of current research is to understand the
molecular mechanisms of this hydrolysis reaction. This will be accomplished
through the exploitation of molecular biology techniques to determine what
the functions of the active site residues are.
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Chapter II:
2.1

SGAP MATERIALS AND METHODS

SgAP in Escherichia coli expression system

Isolating insert DNA from Streptomyces coelicolor
The Streptomyces coelicolor genome was purchased from ATCC. The
primers used were 5-AAT CCC GGG TAG GCG ACA GTT CCC AGA C-3’ and 5’/5PHOS/AAC GTC AAG GCC CAT CTG AGG-3’ and purchased from Integrated
DNA Technology (IDT). The reagents for use in the polymerase chain
reaction (PCR) were purchased from Promega. The PCR was performed on
an Eppendorf Mastercycler Gradient. The PCR products were purified using
Amicon Spin Columns from Millipore. Agarose gel electrophoresis was
utilized to confirm the PCR was successful. For a detailed protocol please see
Appendix A.
Cloning
The vector, pQE30Xa, was purchased from Qiagen. This vector
contains the gene for ampicilin resistance as well as a C-terminal 6x-His tag
and a peptide sequence recognized by Factor Xa protease for removing the
His-tag and has an approximate size of 3.5 kb. The pQE30Xa was digested
with XmaI and StuI (both purchased from New England Biolabs). The
purified PCR product insert was digested with only XmaI (as the PCR product
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was designed with a blunt end that would anneal with the blunt end created
by StuI). Following digestion both reactions were quenched by denaturing
the restriction endonucleases at 65 °C for 10 minutes. The DNA products
were then purified using Amicon Spin Columns.
The digested vector was then treated with shrimp alkaline
phosphatase, purchased from Promega. The use of shrimp alkaline
phosphatase removes phosphates on the vectors digested ends that could
provide the necessary energy to self-ligate. Self-ligation is unlikely because
the ends were incompatible; however, by removing the phosphates with
shrimp alkaline phosphatase the reaction is effectively impossible. Again, the
DNA product from shrimp alkaline phosphatase was purified using Amicon
Spin Columns.
Ligation materials were purchased from Promega. The ligation
reactions were carried out at various ratios of vector to insert (1, 2, 3, 5, 10,
15, 20, 50, 100, and 150).

Of which, success was achieved with a 20:1

vector to insert ratio. The ligation reaction product was used to transform
XL1-blue E. coli. This bacterial cell line is transformed using heat shock
technique and was then plated on LB-Amp (100 ug/mL ampicilin) plates and
grown overnight at 37 °C.
Successful colonies were picked and transferred to a 3 mL liquid LBBroth and shaken overnight at 300 rpm at 37 °C.

This liquid culture was

then tested for possessing a vector with approximate size of 4.5 kb (vector
and insert) using a crude mini-prep (reagents from Qiagen) and then agarose
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gel electrophoresis. Those that appeared to have said band were then
digested with PstI and EcoRI to separate the insert from the vector (XmaI
was not used because it is unnecessarily expensive and the EcoRI and PstI
cut sites are close enough to not be noticed on agarose gel electrophoresis.
Successful ligations following digestion would have two bands, one
representing the vector with an approximate size of 3.5 kb and one
representing the insert with an approximate size of 1 kb. More liquid
cultures for colonies that passed the digestion test were produced, their
vector DNA purified using a perfect prep (kit purchased from Qiagen) and
then sent to Macrogen, USA for sequencing. The sequencing primers used
were: 5’-AAG CGC AGG TGC TTC GTC GG-3’ and 5’-ATC TGA GGC AGC TGG
AGT CGA TCG-3’. For detailed protocols see Appendix A.
Expression of Recombinant Protein
Expression was induced using Isopropyl β-D-1-thiogalactopyranoside
(IPTG) purchased from Fisher BioTech.
A quick expression test was used to determine which of the
successfully ligated colonies was producing more protein than the others.
The colony that appeared to be producing the most recombinant protein
(with an approximate MW of 30 kDa) was then selected for future use, while
glycerol stocks of it as well as the other colonies were stored in –80 °C
storage.
Expression was further tested to determine if temperature, IPTG
concentration, and time would affect whether or not the protein was in the
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soluble or insoluble fractions after the cells were lysed and the fractions
separated. Expression could be observed via SDS-PAGE or Western Transfer.
See Appendix A for detailed protocols.
Purification of Recombinant Protein
Purification of recombinant proteins was performed using an affinity
column utilizing the His-tag engineered into the protein by the pQE30Xa
vector. The His-tag strongly binds Ni-NTA Agarose (purchased from Qiagen).
The insoluble fraction was made soluble using a urea buffer or a guanidium
HCl buffer (which proved cost prohibitive and not effective enough to justify
its continued use). The Ni-NTA Agarose was added to this solution (urea
buffer and insoluble fraction) and subsequently passed through a column
which was then washed and eluted using a pH gradient. Purification could be
observed on via SDS-PAGE or Western Transfer. See Appendix A for detailed
protocols.
Refolding of Recombinant Protein
Several attempts were made to refold the recombinant protein and
gain activity. In most cases dialysis using Spectra/Por dialysis tubing
purchased from Spectrum having a molecular weight cut-off of 6000-8000
daltons was utilized. Various methods of stepping down the urea
concentration to induce folding spontaneously, as well as greatly diluting the
concentration of protein to assist with refolding, were attempted. Following
refolding protocols, concentrating the product was accomplished using an
affinity column and Ni-NTA agarose or using YM-10 membrane and Amicon
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Concentrator. Experiments were performed using reducing agents to reduce
the disulfide bonds. Detergents using Tween-20 or Triton X-100 were used
in different experiments to see if this could dissolve the inclusion bodies and
then removing the detergent with Bio-Beads SM-2 Adsorbents from Bio-Rad.
Including acetone in the refolding buffers was attempted. Refolding
experiments were attempted with ZnII, CaII, both, or neither. All relevant
protocols can be found in Appendix A.
Following refolding protocols a sample was tested for peptidase
functionality using Leucine-para-nitroaniline (L-pNA) in pH 8.0 100 mM
4-(2-hydroxyethyl)-1-piperazineethanesulfonate (HEPES ) buffer with 2 mM
Ca(NO3)2. Activity was monitored at 405 nm. Another sample from the
refolding product was treated with Factor Xa protease to remove the His-tag
and then purified using Amicon Spin Columns. Following purification the
sample was again tested for peptidase activity. This was performed to
ensure that the His-tag was not affecting peptidase activity. Protocols may
be found in Appendix A.
2.2

ScAP in Streptomyces lividans system

Isolating Insert DNA from pUC57
Following the example set by Ni et al.52 the gene was designed to
include the pre-pro sequence from Streptomyces limosus α-amylase and
Streptomyces griseus protease B. This designed gene was custom made by
Genescript and delivered in the pUC57 vector. The pUC57 vector was
transformed into XL1-Blue E. coli and grown on LB-Amp plates. One
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successfully transformed colony was then picked and used to inoculate a
500 mL LB-Amp broth in order to be used with a Maxi-Prep (Qiagen) to
isolate large quantities of the pUC57 vector (with the gene of interest). The
pUC57 vector was then digested using NcoI and SacI. This separated the
vector DNA from the insert (gene of interest) DNA. The vector DNA and
insert DNA were then separated using agarose gel electrophoresis. The
agarose was then separated from the DNA using MO-BIO’s Ultraclean Gel
Spin Kit. All relevant protocols can be found in Appendix B.
Cloning
The vector used for expression in S. lividans, pD730, as well as a
sample of S. lividans was graciously received from Dr. David Wilson, Ph.D
and Dr. Diana Irwin, Ph.D from Cornell University. This vector required a
total digest with SacI and a partial digest with NcoI. Following digestion the
vector was separated using agarose gel electrophoresis and MO-BIO’s
Ultraclean Gel Spin Kit.
The pD730 vector was treated with shrimp alkaline phosphatase and
then purified using Amicon spin columns. A ligation reaction was then
carried out to ligate the gene of interest to the new vector. The ligation
reaction product was then used to transform XL1-Blue E. coli which were
grown overnight at 37 °C on LB-Amp plates. Successfully transformed
colonies were then used to inoculate 3 mL cultures to be used in a crude
mini-prep. Samples from the crude mini-prep that displayed bands on an
agarose gel corresponding to approximate size of 8 kb were considered
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candidates for the digestion. Upon digesting with SacI a successfully ligated
vector and insert construct would have a band 1 kb larger than the vector
alone. These were then selected and sent to MWG sequencing. Four
sequencing primers were utilized. Two of the primers would bind outside the
gene of interest, on the vector, which would sequence into the gene. These
primers were 5’-TCG AAT CCT GCG GAA GGA G-3’ and 5’-GGT ACC GCA TGC
CAT ATG GA-3’. The other two primers would bind inside the gene of interest
and sequence out towards the vector DNA. These primers were 5’-ACA CGA
GTC GTG AAG CC-3’ and 5’-GGG TTA CTT CGT CTA GGA CG-3’. After
sequencing it was apparent that the gene would be sequenced out of frame.
As such site directed mutagenesis primers were designed to delete a single G
nucleotide, thus putting the entire peptide back into frame. These primers
were 5-CCT GCG GAA GGA GCC CCA CCA TGA TGC GCA TCA AGC GGA CC-3’
and 5’-GGT CCG CTT GAT GCG CAT CAT GGT GGG GCT CCT TCC GCA GG-3’.
Site directed mutagenesis was performed using reagents from QuikChange II
from Stratagene. All relevant protocols can be found in Appendix B.
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Chapter III:

SGAP RESULTS AND DISCUSSION

At the time when this project was started the exact genomic sequence
of Streptomyces griseus aminopeptidase (SgAP) was unknown. As such
designing primers in order to use PCR to extract the insert from the S.
griseus genome was not possible. In retrospect, there is the potential to use
“degenerative primers” for PCR. Essentially, a primer for every possible
combination of codons is created and the mix used for PCR. Whichever of
the combinations is the successful will bind and produce the desired inserts
while the incorrect ones will not bind and not produce insert fragments. That
said, there are obvious cost issues, as well as further complications from
having competing primers. The genome of Streptomyces coelicolor was
known, however, and it had previously been shown to have a putative
aminopeptidase similar to SgAP. Moreover, the active sites in both enzymes
were identical, and as such the promiscuous activity seen in SgAP is likely to
also occur in ScAP. Thus, ScAP became the target because the DNA
sequence was known and primers for PCR could be designed to isolate the
ScAP gene while they could not currently be designed to isolate the SgAP
gene. Running the PCR product on a 0.7% agarose gel (Figure 3-1) clearly
shows that the PCR produced a gene with an approximate size of 900 bp, the
appropriate size for the target insert.
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Figure 3-1: 0.7% agarose gel of the product of PCR Reaction. The
bright bands are situated well between the 750bp and 1kb bands on the
molecular weight marker
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Following ligation 28 of the successfully grown colonies were picked
and grown in liquid cultures and their vector DNA isolated using a crude mini
prep protocol. This vector DNA was run on an agarose gel to determine the
size of the recombinant vector and compare that size with the pQE-30 Xa
vector. The insert DNA having a size of 900 bp and the pQE-30 Xa vector
having a size of 3.5 kb it would be possible to see a difference between the
4.5 kb construct (vector and insert) from the vector itself (Figure 3-2).
Crude mini prep products that exhibited an upward shift and the pQE30 Xa were digested with EcoRI (located just before the His-tag of pQE-30
Xa) and PstI (part of the multiple cloning site of pQE-30 Xa). EcoRI and PstI
were chosen instead of XmaI and StuI for fiscally responsible reasons (XmaI)
and because the cut site is not present after the blunt end ligation (StuI). If
the insert were in the construct a band of approximately 900 bp would be
seen. If, however, there were no insert no DNA would appear below the
vector band because the lost DNA would be too small to appear on an
Agarose Gel (Figure 3-3).
Colonies 13, 16, 17 and 22 were processed through a perfect prep and
the product DNA sent to Macrogen for sequencing. Of which colony 16
proved the most successful (Figure 3-4 through Figure 3-6).
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Figure 3-2: 0.7% agarose gel of the product of the crude mini
prep. The last lane in both levels of the gel represents the vector by
itself (pQE-30 Xa) in order to be compared to the products of the crude
mini prep. Lanes with the construct would exhibit an upward shift. Lanes
labeled 3, 9, 10, 11, 15, 16, 17, 22 and 25 exhibit potential and so were
selected for further processing.
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Figure 3-3: EcoRI and PstI digest of crude mini prep product and
pQE-30 Xa vector. Clearly samples 9, 10, 11, 13, 15, 16, 17, and 22
have the appropriate band at 1kb. The band is not at 900bp as was said
before, but this likely is the result of slight increased from cutting at
EcoRI and PstI rather than XmaI and StuI.
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GGCAGACAGCTCGCTATTAGCTTGGCTGCAGGTCGACCCGGGTAGCGACAGTTCCCAGA
CCGCGTAGGCGATGGCGTCGCTGTTGCGGTCCAGGGCCGTGTCGTCGATGTTGGCGGTC
GTGTCGCAGGACGAGTGGTAGCAGCGGTCGAAGGGCTGGCCCACGGTGCCGCCCCACTT
GGCCGCCTGCGCGGACGTCTTGCGGTAGTCCGCGCCGCTGAAGAGGCCGCCCACGGGGA
CGCCCGCGTTCTTGAAGGGTGCGTGGTCGGAGCGTCCGTCGCCCTCGGTCTCGATCTCC
GTGGAGATGCCGATCCCGCTGAAGTAGTCCTTGAACGTCTTCTCGATCGTGGGATCGTC
GTCGTAGACGAAATAGCCGGGGTTGGGCGAGCCGATCATGTCGAAGTTCAGGTAACCGC
TGATCTTCGCGCGTTCCGCGGAGCCGAGGCTGTTGACGTAGTAGCGGGAGCCGACGAGT
CCCAGCTCCTCCGCGCCCCACCAGGCGAAGCGCAGGTGCTTCGTCGGCTGGTAGCCGGA
CCGGGCGACGGCGAGCGCGGTCTCCAGGACGGCCGAGGAGCCGGAACCGTTGTCGTTGA
TGCCGGGCCCGGAGGCGACACTGTCCAGATGTGACCCGGCCATGACAATCTGACTCGCG
TCGCCGCCGGGCCAGTCGGCCGTCAGGTTGTACCCGGTGCGGCCCGAGGCGCTGAACTG
CTGGACGCGGGTGGTGAACCCGGCGGCGTCCAGCTTGGCCTTCATGTAGTCGAGGGAGG
CCCGGTAGCCGGCGCGGCCGTGGGCGCGGTTGCCGCCGTTCGCCGTGGCGATCGACTCC
AGCTGCCTCAGATGGGCCTTGACGTTCCTTCCCTCGATACCAGATCCAGAGCCAGATCC
GTGATGGTGATGGTGATGCGATCCTCTCAT

Figure 3-4: Sequencing results from Macrogen.

MRGSHHHHHHGSGSGSGIEGRNVKAHLRQLESIATANGGNRAHGRAGYRASLDYMKAKL
DAAGFTTRVQQFSASGRTGYNLTADWPGGDASQIVMAGSHLDSVASGPGINDNGSGSSA
VLETALAVARSGYQPTKHLRFAWWGAEELGLVGSRYYVNSLGSAERAKISGYLNFDMIG
SPNPGYFVYDDDPTIEKTFKDYFSGIGISTEIETEGDGRSDHAPFKNAGVPVGGLFSGA
DYRKTSAQAAKWGGTVGQPFDRCYHSSCDTTANIDDTALDRNSDAIAYAVWELSLPG
STCSQANSELSA

Figure 3-5: Translation of sequence results from Macrogen. Bold and
underlined areas are the result of the vector. This sequence gives a protein
with an estimated molecular weight of 32.27kDa.
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16
ScAP
16
ScAP
16
ScAP
16
ScAP
16
ScAP
16
ScAP

MRGSHHHHHHGSGSGSGIEGRNVKAHLRQLESIATANGGNRAHGRAGYRASLDYMKAKLD
--------------APDIPIANVKAHLRQLESIATANGGNRAHGRAGYRASLDYMKAKLD
---------------------***************************************
AAGFTTRVQQFSASGRTGYNLTADWPGGDASQIVMAGSHLDSVASGPGINDNGSGSSAVL
AAGFTTRVQQFSASGRTGYNLTADWPGGDASQIVMAGSHLDSVASGPGINDNGSGSSAVL
************************************************************
ETALAVARSGYQPTKHLRFAWWGAEELGLVGSRYYVNSLGSAERAKISGYLNFDMIGSPN
ETALAVARSGYQPTKHLRFAWWGAEELGLVGSRYYVNSLGSAERAKISGYLNFDMIGSPN
************************************************************
PGYFVYDDDPTIEKTFKDYFSGIGISTEIETEGDGRSDHAPFKNAGVPVGGLFSGADYRK
PGYFVYDDDPTIEKTFKDYFSGIGISTEIETEGDGRSDHAPFKNAGVPVGGLFSGADYRK
************************************************************
TSAQAAKWGGTVGQPFDRCYHSSCDTTANIDDTALDRNSDAIAYAVWELSLPGSTCSQAN
TSAQAAKWGGTVGQPFDRCYHSSCDTTANIDDTALDRNSDAIAYAVWELSQ--------**************************************************---------SELSA
-----

Figure 3-6: ClustalW2 alignment of colony 16 translation result
aligned with ScAP.
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Figure 3-7: Successful purification.

MW= molecular weight marker, C1,

C2, D, and E coorespond to washes and elutions as discussed in protocols in
Appendix A. FT= Flow through.
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Clearly, based upon the sequencing data, the translation of it, and its
alignment with ScAP the cloning was successful. As such colony 16 became
the focus for expression, purification and refolding attempts.
Based upon the purification shown in Figure 3-7, it is evident that
purification was successful, however, so much protein is being produced that
all the Ni-NTA agarose used during the purification process is saturated with
His-tagged protein and thus the excess His tagged protein is lost in the flow
through and wash steps. Thus indicating that more Ni-NTA agarose should
be used in future purifications. After another successful purification, dialysis
was performed on the E fraction to remove the denaturant so that the
protein might refold spontaneously. After multiple changes of the dialysis
buffer a precipitate formed and coated the dialysis bag but was easily
dislodged into the dialysis buffer. Centrifugation separated the dialysis buffer
from the precipitate and samples of both supernatant and precipitate were
taken, and mixed with 2x SDS-PAGE buffer. The results of which are shown
in Figure 3-8.
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Figure 3-8: Failed refolding protocol due to precipitation. MW =
molecular weight, E= fraction E before dialysis, S= dialysis supernatant, P=
dialysis precipitate.
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Unfortunately, the majority of the protein seemed to have been in the
precipitate. Furthermore, the little protein that remained in the supernatant,
upon concentrating through a YM-10 membrane showed no activity with LeupNA. Regarding the identity of the second band in the E fraction it seems
possible that it is the result of some proteolytic cleavage of ScAP during
purification possibly by some enzyme native to E. coli, or another unknown
phenomenon.
After trying unsuccessfully many times to refold the protein and
achieve activity it was found that expression at 25.7 °C and 0.1 mM IPTG
shifted some of the expressed protein to the soluble fraction (while the
majority still was in the insoluble fraction). The purification proved
challenging however, as shown in figure 3-9.
Purification of the soluble fraction was never achieved to the level that
was attained by the insoluble purification. Nonetheless, the elution fractions
were tested for aminopeptidase activity against Leu-pNA but activity was not
detected. To ensure that this was not due to the His-tag Factor Xa was
utilized to remove the His tag. To ensure the removal of the His tag a
Western blot was used.
The western blot clearly shows that the His tag was removed by Factor
Xa (Figure 3-10). The Factor Xa protease reaction dilutes the sample by half,
and given the sensitivity of the Western blotting technique it is impossible to
have the quality bands we have in the untreated lanes and nothing in the
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Figure 3-9: Purification from soluble fraction. From Left to right:
MW, Wash 1, Elutions 1 though 4. The dark band on the bottom is
lysozyme, a byproduct of the purification and lyses of the cellular wall
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Figure 3-10: Western blot results from soluble purification and
Factor Xa. A side by side comparison of the SDS-PAGE Gel, and a western
blot attained from an identical gel. Lanes in both (from right to left)
correspond to: Molecular weight marker, Wash 1, Elutions 1 through 4,
4Units Factor Xa 2 hours, 4Units Factor Xa 3 hours, 10U Factor Xa 2 hours,
10U Factor Xa 3 hours, 20U Factor Xa 2 hours, 20U Factor Xa 3 hours.
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treated bands based simply upon a 50% reduction. As for the smaller bands
that show up in the last three elution samples it is likely that these are the
result of proteolytic cleavage during the purification process by an unknown
peptidase. The new bands shown in the treated lanes represent the Factor
Xa. Factor Xa is 44kDa, however this is really two polypeptides connected by
a disulfide bond.
The SDS-PAGE loading dye reduces the disulfide bond thereby
separating the larger polypeptide from the smaller one, hence the large band
at approximately 30 kDa and the smaller band above the lysozyme band.
Testing the Factor Xa treated samples with Leu-pNA revealed no activity.
Following months of attempts to get the insoluble fraction to refold to
an active enzyme and the lack of activity with the soluble fraction enzyme it
became apparent that the possibility that the protein cannot fold correctly in
E. coli should be investigated. An article by Henderson et al55 compared two
putative enzymes from S. griseus that revealed that the propeptide is likely
vital for secretion of proteases in S. griseus. Given that SgAP is a putative
enzyme it too must have a propeptide region, although neither DNA nor
amino acid sequence has yet been published. Furthermore, a fully folded
protein is not able to be secreted as it cannot diffuse through the plasma
membrane. Therefore, in the case of S. griseus the protein does not fold in
the cytosol of the bacteria but rather folds as it is excreted in the medium in
which the bacteria is growing. Moreover, the protein may not fold correctly
as it is translated on the ribosome, that is, in S. griseus with the propeptide
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sequence intact, chaperone proteins bind and prevent folding and so the first
sequences to be translated might not fold until later parts have been able to
fold. The active conformation may not be the lowest potential energy, but
rather located in an energy trough the result of folding in a particular order.
In the E. coli expression system used herein, the peptide lacks a
propeptide sequence and furthermore given the very different physiology of
S. griseus and E. coli the propeptide sequence from S. griseus may not have
any corresponding chaperone proteins in E. coli. As such, expressing ScAP in
an expression system more closely related to the native system may yield
more positive results. One technique for doing this was published by Ni et
al52 in which they expressed and purified recombinant Streptomyces griseus
in S. lividans. As the propeptide sequence was unknown Ni et al. designed
their own using the amino terminus of the signal peptide from S. griseus
protease B and the carboxy terminus of the signal peptide from S. limosus
alpha-amylase. The exact sequence of the propeptide sequence of Ni et al.
was not published, however, a propeptide sequence using hints in their
article was put together (Figure 3-11).
The construct sequence for rScAP was received in a plasmid and thus
required digestion the use of agarose gel separation and purification (Figure
3-12).
The vector pD730 was generously supplied by Dr. David Wilson and
Dr. Diana Irwin from Cornell University. pD730 is designed for multiplication
in both E. coli and S. lividans but only for expression in S. lividans. In
63

SgPB signal peptide53
MRIKRTSNRSNAARRVRTTAVLAGLAAVAALAVPTANA
Alpha Amylase signal peptide54
MARRLATASLAVLAAAATALTAPTPAAAA
ScAP
APDIPIANVKAHLRQLESIATANGGNRAHGRAGYRASLDYMKAKLDAAGFTTRVQQFSASGRTGY
NLTADWPGGDASQIVMAGSHLDSVASGPGINDNGSGSSAVLETALAVARSGYQPTKHLRFAWWGA
EELGLVGSRYYVNSLGSAERAKISGYLNFDMIGSPNPGYFVYDDDPTIEKTFKDYFSGIGISTEI
ETEGDGRSDHAPFKNAGVPVGGLFSGADYRKTSAQAAKWGGTVGQPFDRCYHSSCDTTANIDDTA
LDRNSDAIAYAVWELSQ
Construct
MRIKRTSNRSNAARRVRTTAVLAGLAAVAALTAPTPAAAAAPDIPIANVKAHLRQLESIATANGG
NRAHGRAGYRASLDYMKAKLDAAGFTTRVQQFSASGRTGYNLTADWPGGDASQIVMAGSHLDSVA
SGPGINDNGSGSSAVLETALAVARSGYQPTKHLRFAWWGAEELGLVGSRYYVNSLGSAERAKISG
YLNFDMIGSPNPGYFVYDDDPTIEKTFKDYFSGIGISTEIETEGDGRSDHAPFKNAGVPVGGLFS
GADYRKTSAQAAKWGGTVGQPFDRCYHSSCDTTANIDDTALDRNSDAIAYAVWELSQIEGRHHHH
HH
Figure 3-11: Construct sequence for Recombinant ScAP (rScAP) to
be expressed in S. lividans. The Grey area represents the Factor Xa cut
sequence as well as the His-tag for purification purposes.

64

Figure 3-12: rScAP digest out of pUC57 vector as shown on 0.7%
Agarose Gel
Lane 1: Molecular Weight Marker (From bottom: 500 bp, 1 kb,
1.5 kb, 2.0 kb, 3.0 kb, 4.0 kb, 5.0 kb, 6.0 kb, 8.0 kb, 10.0 kb)
Lane 2: pUC57 (supercoiled and nicked circular)
Lane 3: pUC57 Digested with SacI
Lane 4: pUC57 Digested with SacI and NcoI.
Insert is lower band with ~1000bp
Lane 5: Purified product of Insert (faint but present and the
concentration can be determined using A260
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preparation for ligation it needed to be digested and the correct fragment
separated by agarose gel electrophoresis and purified from the gel (Figure 313). The vector pD730 had to be subjected to a partial digest protocol
because it had various NcoI recognition sequences. The fragment required
for ligation had a size of 7619 bp while the entire vector has a size of 7654
bp. As such, there would be no way to separate them, however, the
incorrectly cut fragments would all be considerably smaller, the closest of
which would be 6.3 kb. The highest band on the gels with the double cuts is
a mixture of two populations, the first a single cut vector, and a double cut
(correct two cuts). The ratio between these two populations depends on the
amount of time exposed to NcoI and as such for purification out of the gel
the 20 minute sample was chosen. It appears that 2 hours of exposure to
the second restriction enzyme is enough to remove the residual uncut vector
there should therefore be no difference in population between the 20 min
NcoI/2 hour SacI and the 20 min NcoI/24 hour SacI top bands. As such
purification was chosen on the 20 min NcoI/2 hour SacI sample and the
concentration was determined by A260.
Ligation with the vector should not prove a difficult situation despite
the vector being a mixed population of single cut vectors and correctly
double cut vectors. The logic behind this is first that the insert can only
ligate with a correctly cut vector due to compatibility issues between the
ends. Secondly, the vector is treated with Calf intestinal alkaline
phosphatase. This removes the phosphates from the 5’ ends of the DNA
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Figure 3-13: Partial digest of pD730 on a 0.3% Agarose gel.
Lane 1: Molecular weight marker (From bottom 500 bp, 1.0 kb,
1.5 kb, 2.0 kb, 3.0 kb, 4.0 kb, 5.0 kb, 6.0 kb, 8.0 kb, 10.0 kb)
Lane 2: uncut pD730.
Lane 3: pD730 digested with Sac.
Lanes 4-6: 10min exposure to NcoI with varied exposure to SacI.
Lanes 7-9: 15min Exposure to NcoI with varied exposure to SacI.
Lanes 10-12: 20min Exposure to NcoI with varied exposure to SacI.
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which prevents easy self ligation. This prevents the vector from self-ligating
and therefore becoming a working vector that can transform bacteria but
yields no value due to the lack of an insert.
Successfully transformed bacteria that grew on LB-Amp agar plates
were grown in liquid broth cultures and their DNA extracted and digested
with SacI. The product of was run on an agarose gel and is displayed on
Figure 3-14. While in no way is the Figure 3-14 gel perfect, especially when
compared to above Figure 3-12 and Figure 3-13, it is not used by itself to
determine which bacterial conlonies were successfully transformed.
Sequencing is the only way to truly determine if ligation was successful as it
will also show if the sequence is in frame and if expression will proceed
correctly. The determined sequence is shown in Figure 3-15.
The translation from colony five did not code for the rScAP as
expected, Figure 3-16. Upon evaluation of the Sequencing DNA the reason
for this becomes apparent in that the G as highlighted in Figure 3-15 is extra,
a byproduct of engineering an NcoI cut site so the insert could be used with
pD730. This extra G nucleotide throws the sequence out of frame. At the
time of writing this our laboratory is currently working on eliminating this
extra G nucleotide, the new translation of which is expected to push
eliminate the frameshift. The translation of the expected sequence without
the extraneous G is shown in Figure 3-17, and the alignment with the
designed construct (figure 3-11) is shown in Figure 3-18.
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Figure 3-14: Crude Mini prep digested with SacI. Dark horizontal line
indicates furthest region the Vector lane reached. Samples with band above
this line may have insert ligated and are selected for sequencing. Therefore,
samples 2, 5 and 15 were chosen.
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TCCAGCGGAAGGAGCCCCACCATGGATGCGCATCAAGCGGACCTCCAACCGCAGCAACG
CCGCGCGCCGAGTCCGCACCACGGCGGTCCTGGCGGGACTCGCAGCAGTGGCAGCATTG
ACCGCCCCCACCCCGGCGGCGGCGGCGGCACCGGACATCCCGATCGCGAACGTCAAGGC
CCACCTCCGGCAGCTCGAGAGCATCGCGACCGCCAACGGAGGCAACCGGGCCCACGGCC
GTGCGGGTTACCGGGCCTCGCTCGACTACATGAAGGCGAAGCTGGACGCCGCCGGCTTC
ACGACTCGTGTGCAGCAGTTTAGCGCGTCGGGCCGTACCGGGTACAACCTGACCGCCGA
CTGGCCCGGCGGCGACGCGTCCCAGATCGTGATGGCCGGGAGCCACCTCGACTCGGTGG
CTTCCGGCCCCGGTATCAACGACAACGGCTCCGGCAGTAGCGCCGTCCTGGAGACGGCG
CTGGCGGTCGCCCGATCGGGTTACCAGCCGACCAAGCACCTCCGGTTCGCCTGGTGGGG
CGCGGAGGAGCTGGGCCTGGTCGGCTCCCGGTACTACGTCAACTCGCTGGGCAGCGCCG
AGCGCGCCAAGATCAGCGGGTACCTGAACTTCGACATGATCGGCTCCCCGAACCCGGGT
TACTTCGTCTACGACGACGACCCGACGATCGAGAAGACCTTCAAGGACTACTTCTCCGG
GATCGGCATCTCCACGGAGATCGAGACCGAGGGCGACGGACGCTCCGACCACGCACCCT
TCAAGAACGCGGGAGTCCCGGTCGGCGGCCTGTTCAGCGGCGCCGACTACCGCAAGACC
TCCGCGCAGGCGGCCAAGTGGGGCGGCACTGTCGGCCAGCCCTTCGACCGCTGCTACCA
CTCCAGTTGCGACACCACGGCCAACATCGATGACACGGCCCTGGACCGTAACAGCGACG
CCATCGCATACGCCGTCTGGGAGCTGTCGCAGATCGAGGGCCGGCATCACCACCACCAC
CACGGTACC
Figure 3-15: Sequencing DNA from Colony 5 using internal and
external sequencing primers.

SSGRSPTMetDAHQADLQPQQRRAPSPHHGGPGGTRSSGSIDRPHPGGGGGTGHPDRERQGPPPA
AREHRDRQRRQPGPRPCGLPGLARLHEGEAGRRRLHDSCAAVStopRVGPYRVQPDRRLARRRRV
PDRDGREPPRLGGFRPRYQRQRLRQStopRRPGDGAGGRPIGLPADQAPPVRLVGRGGAGPGRLP
VLRQLAGQRRARQDQRVPELRHDRLPEPGLLRLRRRPDDREDLQGLLLRDRHLHGDRDRGRRTLR
PRTLQERGSPGRRPVQRRRLPQDLRAGGQVGRHCRPALRPLLPLQLRHHGQHRStopHGPGPSto
pQRRHRIRRLGAVADRGPASPPPPRY
Figure 3-16: Translation of Sequence DNA from Colony 5.

SSGRSPTMetMRIKRTSNRSNAARRVRTTAVLAGLAAVAALTAPTPAAAAAPDIPIANVKAHLRQ
LESIATANGGNRAHGRAGYRASLDYMKAKLDAAGFTTRVQQFSASGRTGYNLTADWPGGDASQIV
MAGSHLDSVASGPGINDNGSGSSAVLETALAVARSGYQPTKHLRFAWWGAEELGLVGSRYYVNSL
GSAERAKISGYLNFDMIGSPNPGYFVYDDDPTIEKTFKDYFSGIGISTEIETEGDGRSDHAPFKN
AGVPVGGLFSGADYRKTSAQAAKWGGTVGQPFDRCYHSSCDTTANIDDTALDRNSDAIAYAVWEL
SQIEGRHHHHHHGT
Figure 3-17: Translation of Sequence DNA from Colony 5 with
extraneous G deleted.
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Con--------MRIKRTSNRSNAARRVRTTAVLAGLAAVAALTAPTPAAAAAPDIPIANVKAH
5 SSGRSPTMMRIKRTSNRSNAARRVRTTAVLAGLAAVAALTAPTPAAAAAPDIPIANVKAH
****************************************************
ConLRQLESIATANGGNRAHGRAGYRASLDYMKAKLDAAGFTTRVQQFSASGRTGYNLTADWP
5 LRQLESIATANGGNRAHGRAGYRASLDYMKAKLDAAGFTTRVQQFSASGRTGYNLTADWP
************************************************************
ConGGDASQIVMAGSHLDSVASGPGINDNGSGSSAVLETALAVARSGYQPTKHLRFAWWGAEE
5 GGDASQIVMAGSHLDSVASGPGINDNGSGSSAVLETALAVARSGYQPTKHLRFAWWGAEE
************************************************************
ConLGLVGSRYYVNSLGSAERAKISGYLNFDMIGSPNPGYFVYDDDPTIEKTFKDYFSGIGIS
5 LGLVGSRYYVNSLGSAERAKISGYLNFDMIGSPNPGYFVYDDDPTIEKTFKDYFSGIGIS
************************************************************
ConTEIETEGDGRSDHAPFKNAGVPVGGLFSGADYRKTSAQAAKWGGTVGQPFDRCYHSSCDT
5 TEIETEGDGRSDHAPFKNAGVPVGGLFSGADYRKTSAQAAKWGGTVGQPFDRCYHSSCDT
************************************************************
ConTANIDDTALDRNSDAIAYAVWELSQIEGRHHHHHH-5 TANIDDTALDRNSDAIAYAVWELSQIEGRHHHHHHGT
***********************************
Figure 3-18: Alignment results of modified Colony 5 sequencing DNA
to the construct rScAP. Alignment is 100% accurate, excess amino acids
are the translation of vector sequences.
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Chapter IV:

CONCLUSION TO SGAP

Like countless biochemists and biologists before, the complex and
still unknown mechanisms of protein folding have caused infinite frustration
and near psychosis for all involved. Given the previous success of Ni et al.52
in expressing the recombinant SgAP in a similar expression system to the
native SgAP there is hope that using S. lividans as an expression system for
ScAP will prove fruitful. At present a plasmid that can easily be modified
(deleting the superfluous G nucleotide) is available. Furthermore, by
following the roadmap set forth by Ni et al.52 acquiring the first unmutated
recombinant ScAP should be merely a matter of time. Considering the
simplicity of doing site directed mutagenesis the mutants should follow
quickly. The only foreseeable difficulty could be the time to learn and adjust
the laboratory accordingly to using a new bacterium (S. lividans) including
learning the new techniques for transformation and expression. Isolating the
protein after expression should prove simple as S. lividans will secrete rScAP
into the growth medium and the presence of the engineered His-tag on rScAP
will facilitate easy purification.
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Chapter V:
5.1

INTRODUCTION TO HISTATIN-5 N-TERMINUS

Antimicrobial Peptides (AMPs)
One of the most interesting class of peptides are the antimicrobial

peptides (AMP), owing to their broad spectra of microbicidal functionality.
Alternatively, they are known as cationic host defense peptides.55 In addition
to the antimicrobial activity, AMPs have various essential functions in the
host’s innate immunity. Thus, the latter name better describes its overall
function.
AMPs can be ubiquitously found in nature, ranging from plants to
humans.55 The exact classification for AMPs is broad; in general, the length
of the peptide ranges anywhere from 12 to 50 amino acids, with 2–9
positvely charged residues and at most 50% hydrophobic residues.55
Furthermore, they are commonly thought to have similar three dimensional
structures due to the similarities of their compositions. In hydrophobic
environments, such as that of the plasma membrane, they generally have βsheet or α-helix conformations. Both secondary structures are well suited for
membrane spanning roles, which is a common antimicrobial mechanism
among AMPs and is necessary for many of them to function successfully as
antimicrobials.56-58 The amphipathic nature of these peptides enables
insertion into the membrane, which leads to pore formation. This, in turn,
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disrupts the integrity of the cell membrane, leading to cell lysis and loss of
metabolites to the extracellular environment.59-62 It is interesting that AMPs
are selectively active toward the foreign but not host cell; this feat is
accomplished by the slight difference in the composition of celluar
membranes. The bacterial membranes are more negatively charged on the
surface, thus enabling the positively charged AMPs to interact quite strongly.
However, this is not how all AMPs work. They have also been proposed to
play major roles in the host’s innate and adaptive immunity,63-66 including
lysing of tumor cells,67 preventing excitotoxicity caused by
lipopolysaccharide(LPS),68 and acting as chemical markers during antiinflammatory responses and angiogenesis.68 Furthermore, some AMPs
function in a fashion similar to normal antibiotics; they bind to the microbial
enzyme or protein and inhibit its function. Examples include attacins, which
block the transcription of omp gene in E. coli,69 Buforin II, which binds DNA
and RNA,70 or pyrrhocoricin, which binds and inactivates the chaperone
DnaK.71
It seems only natural that AMPs have generated a storm of commercial
interests. The potential for possible therapy, combined with the alarming
decrease in efficacy for current generation of antibiotics have brought money
and enthusiasm to this search. Unfortunately, only few AMPs have made
significant progress, in part to the need for high doses and the low
therapeutic index, making them unacceptably dangerous for medicinal use.72
Nonetheless, a couple of successful AMPs have been brought to the market.
These have a common feature in that they are topical, enabling them to have
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a high local but low systemic concentration.73 Further research may lead to a
better understanding both its toxicity to humans and interaction with
microbial targets, which could lead to more pharmaceutical and commercial
interests.
5.2

Histatin-5
Histatins (Hs) are found in the saliva of higher primates and named

due to their histidine rich character.74-75 The wide range of microbicidal
activity of Hs includes one of the most prevalent fungi, Candida albicans,76-78
and several families of bacteria.79 Interestingly, only two separate genes are
responsible for the expression of histatins. These genes, HTN1 and HTN2,
encode the primary sequence for histatin-1 and histatin-3, respectively.80
The remaining Hs variants (up to 50) found in the whole saliva are the
products of post translational modification, namely proteolytic cleavage, of
either Hs-1 or Hs-3.81 Histatin-5, for example, consists of the first 24 amino
acid residues of Hs-3 (DSHAKRHHGY10 KRKFHEKHHS20 HRGY).81
One interesting aspect of Histatin-5 is that while it is clearly
antimicrobial, its exact mechanism remains under debate. There are three
schools of thought currently on this subject. The first being proposed by
Edgerton et al.82-85 is that the histatin-5 induces the non-lytic loss of ATP,
which then binds to purinergic-like receptors which initiate apoptosis. In this
mechanism, the peptide interacts with the heat shock proteins (Ssa1/2) of
C. albicans and is internalized. Once inside the cell it binds to the potassium
transporter (TRK1) which leads to the loss of cellular integrity, and cellular
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death.82-85 The second proposed mechanism by Oppenheim et al.64-65
involves the breakdown of the yeast’s respiratory machinery. In this
mechanism the peptide is internalized due to the electrochemical gradient
(the inside of the cell being negative and histatin-5 being very positive).
Once inside, it migrates to the mitochondria and is again internalized via a
similar mechanism. Histatin-5 is able to disrupt the electron transfer process
of the mitochondria which leads to the accumulation of reactive oxygen
species, oxidative stress and finally cellular death.86-87
A third mechanism has more recently been proposed by Mochon et
al.88 which contradicts both Oppenheim64-65 and Edgerton82-85 by saying that
Histatin-5 does indeed cause a lytic event, although is unconventional in how
it does that. In this mechanism physiological levels of Histatin-5 were shown
to create a single breach in the membrane allowing the rapid loss of ATP and
K+. This single breach site is the result of the fact that Histatin-5 acts this
way only because of the membrane potential. Upon creation of one lytic site,
the membrane potential is lost and therefore a second lytic site is not
possible.88
Amino acid residues such as histidine, serine, tyrosine, and acidic
aspartate and glutamate are well known to participate in metal binding.89
The primary sequence of Hs 5 consists of seven histidines, two serines, two
tyrosines, one glutamate, and one aspartate, creating multiple potential
metal-binding sites.81 The presence of multiple metal-binding sites has been
confirmed by a number of studies using calorimetric, and spectroscopic
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techniques. According to previous studies, there are three common metalbinding motifs, which are the zinc-binding HEXXH13 the copper binding
HXXXH,90 and the copper- and nickel-binding motif ATCUN (Amino Terminal
CuII and NiII Binding) consisting of DSH.91
Gusman et al.92 used spectrophotometric competition assays to
determine whether Hs-5 binds both CuII and/or ZnII. This study showed that
free murexide, a metallochrome, in solution absorbs maximally at 520 nm,
and upon addition of CuII or ZnII, the peak shifts to 500 nm, indicating the
metal-murexide complex formation. Addition of Hs-5 to this solution shifted
the absorption maximum back to 520 nm, which clearly indicates the
removal of metal ion from the original complex by the peptide to give free
murexide. The absorption at 520 nm due to free murexide was further
confirmed by using EDTA, a good metal chelator, in place of the Hs-5
peptide.92
Melino et al.93 used UV-vis spectroscopy to show the similarities
between Histatin-5 N-terminus metal binding and that of the ATCUN region
of human serum albumin. In this study, the disruption of the ATCUN site by
substituting His-3 into Ala-3 drastically changed the UV-Vis spectrum.93 The
major flaw of both these studies is that it did not go far enough into
investigating to what stoichiometric ratios does metal bind. Given the
bountiful nature of Hs-5’s primary structure with regard to its possible metalbinding ligands, it seems obvious that this peptide can bind more than one
metal ion. Nonetheless, these studies overlooked or discounted such
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possibility. Brewer and Lajoie94 investigated the potentials of Hs-5 in
complexing with more than one metal ion using electrospray ionization mass
spectrometry (ESI-MS). The mass difference between one versus multiple
metal ion bound complexes can be determined using ESI-MS. In addition,
the study clearly showed that Hs-5 has different affinities for different metal
ions under different conditions. For instance, with 5:1 metal-to–peptide
stoichiometric ratio in solution three CuII ions were bound to Histatin-5 (but
no FeII).94 With a change in the pH from 6.5 to 7.0 another CuII ion is
bound.94

The ratio of metal to peptide used in preparation greatly affects

the number of bound metals.94 For instance when prepared with a 2:1 CuII
to peptide ratio only one CuII ion is bound, whereas at a 10:1 ratio four CuII
ions are bound.94 Again, this study is limited to only the metal-binding ability
of Hs-5 and does not provide mechanistic information toward its in vivo
antimicrobial activity.
The above potential mechanisms, particularly the ones proposed by
Mochon et al.88 and Edgerton et al.,82-85 provide an interesting situation that
arises when one takes in to account the metal binding characteristics of
Histatin-5. Both Mochon and Edgerton emphasize the importance of the
positive charge on Histatin-5. For one, the positive charge is necessary for
the peptide to interact with the negatively charged outer leaflet of the plasma
membrane. Second, the positive charge provides a necessary function in
making entrance into the cell favorable based on the net negative charge
inside the cell. Changing Lys-13 to Glu and Arg-22 to Gly decreased
candidacidal activity significantly.95 It was later shown that these changes
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effect the entrance into the cell and this could be the cause of the decreased
candidacidal activity.88 The overall charge of the peptide is certainly
important for its function as an AMP. Would metal binding affect this activity
by neutralizing the apparent charges? If so, what metal binding species is
present in the human salivary environment? Further, would this species lack
sufficient charge to attack C. albicans as Edgerton and Mochon proposed? In
consideration of the metal-binding ability of Hs-5 it is essential to determine
the possible role of CuII in the in vivo antimicrobial activity of Hs-5. In fact, a
previous study suggested a possible involvement of metal, particularly Zn, in
the interaction of Hs-5 and cellular membranes. The study showed that Hs-5
can selectively fuse the negatively charged small unilamellar vesicles in the
presence of Zn.96
In order to investigate how the binding of metals affects the
catecholase properties of Hs-5, Tay97 used UV-vis spectroscopy to monitor
catechol oxidation (using 3-methyl-2-benzothiazolinone hydrazone
Hydrochloride as an indicator for o-quinone, the oxidative product of
catechol) by Hs-5 upon addition of various ratios of CuII. It was evident that
there was no activity until greater than 1 equivalent of CuII was added and a
steady increase in activity was observed until approximately 8 equivalents of
CuII were added.97 In context of the ESI-MS study,94 it seems unlikely that
all 8 equivalents of CuII were bound to the peptide, but rather that maximal
activity should fall somewhere between 3 and 4 CuII ions bound. This study
was further refined using the 4,5-di-chloro-catechol (DCC) as the substrate.
The benefit of using DCC is that catalytic turnover of DCC is approximately
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200-fold smaller than that of catechol. As such, any metal-ligand-substrate
complex that forms should exist long enough to be observed using optical
UV-Vis spectroscopy; whereas catechol would form complex and react too
quickly to be well observed. The result of this experiment revealed a 3:1
DCC:CuII4-Hs-5 ratio. This infers that three metal centers exist in the peptide
each of which can bind DCC. Tay97 was further able to assign metal binding
sites using CoII titration as monitored by NMR. However, in this experiment
only two metal sites were assigned, the first being the HEXXH ZnII binding
motif (or for that matter the HXXXH CuII-binding site) and the second being
the DSH ATCUN site. The third site was not apparent using NMR with up to 6
equivalents of CoII. This of course, based on the ESI-MS study by Brewer
and Lajoie,94 may be a result of the rather large differences that may arise
with a variation in metals used. At a 4:1 metal-to-peptide ratio using CuII we
may see three metals bind, but with CoII perhaps only two may bind. Further
titration of CoII may have revealed the third binding site.
These questions however are outside of the scope of this current
study. The primary interest is not in its ability to kill C. albicans but rather in
its ability to utilize metal to perform oxidative chemistry. In recent years,
there has been a great deal of interest in the study of peptides that have the
ability to catalyze enzymatic reactions. The idea is that these peptides can
be utilized as model systems to study the mechanisms for the more complex
proteins. The goal of my research is to reveal greater insight into copper ion
chemistry using Histatin-5 as a natural system. So, while there is obvious
direct medical relevance in studying any AMP, the exact nature of this study
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deals not with the medical significance of the subject, but rather with the
Histatin-5’s other unique properties, namely oxidative chemistry under near
physiological conditions in vitro. In determining the oxidative properties of
the full length Hs-5 three potential metal binding sites for CuII were
observed. Theoretically, by synthesizing the peptide in two separate
fragments one might be able to better isolate the proposed metal binding
sites. From this better characterization of the metal binding sites, their
affinities and oxidative properties may be determined.
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Chapter VI:

HISTATIN-5 N-TERMINUS MATERIALS AND
METHODS

Histatin-5 and the N-terminal histatin-5 fragment (Hs-5N) were
synthesized and purified and characterized at the University of South Florida
Peptide Synthesis and Mass Spectroscopy Center. The concentration was
determined using A280 with ε=1440 M—1 cm—1. Anhydrous copper sulfate
and HEPES was purchased from Fisher Scientrific. pyrocatechol (~99%) and
3-methyl-2-benzothiazolinone hydrazone hydrochloride monohydrate (98%),
MBTH, were acquired from Sigma–Aldrich Inc. The o-quinone from catechol
oxidation reacts with MBTH to form a colored adduct that with a maximum
absorption at 500 nm (ε= 32500 M—1 cm—1). All spectroscopic studies were
conducted on a Cary-50 UV/Vis spectrometer unless stated otherwise.
6.1

Metal Binding Studies
Metal binding was monitored in two ways. The first method was CuII

titration while monitoring catechol oxidation at 500 nm. In the second
method the formation of CuII-Hs-5N complex was monitored directly over
200-800 nm range. Catechol oxidation experiments were conducted over a
range of 0.0-5.0 equivalents of CuII with 1.0 mM catechol and equal molarity
of the o-quinone-specific indicator (MBTH) in 100 mM HEPES at pH 7.0 with
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1.01 μM Hs-5N. Optical CuII titration was performed using a CuII range of
0.0-20.0 equivalents with 100 μM Hs-5N in 100 mM HEPES at pH 7.0.
6.2

Kinetics Studies
Kinetics experiments were monitored at 500 nm from the red MBTH-o-

quinone adduct. Catechol and MBTH were varied from 0.0 to 6.4 mM were
incubated with 1.0 μM Cu2II-Hs-5N in 100 mM HEPES at pH 7.0. The initial
rate was determined from the slope of the change in absorbance versus time
over a period of 0-5 minutes in the linear range. Kinetic constants were
determined using Sigma Plot 11 by fitting data to the appropriate equations.
A mechanistic Job plot was constructed by continuously varying the mol
fraction between the CuII-Hs5N complex and the substrate, while keeping the
overall concentration constant. Kinetic studies were also performed in the
presence of hydrogen peroxide, H2O2. In one experiment H2O2 was titrated
over a range of 0.0 to 32.0 mM while holding constant the catechol, MBTH
and CuII-Hs5N constant at 3.2 mM, 3.2 mM and 1.5 μM, respectively. For
another series of experiments the peroxide concentration was held constant
while varying the catechol and MBTH concentrations (between 0.0 to 6.0 mM
catechol/MBTH). The oxidation of catechol was determined in the presence
of several concentrations of H2O2 ranging 0.0-32.0 mM.
6.3

DCC Binding Studies
4,5-di-chloro-catechol, DCC, was used to study the substrate binding

due to its significantly smaller reactivity compared to catechol, in order to
monitor the interaction between this substrate and the Cu2II-Hs-5N complex.
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DCC was dissolved in DMSO due to its low solubility in water or buffer. Up to
3 equivalents of DCC was titrated into Cu2II-Hs-5N complex. The binding was
monitored over the 200-800 nm.

An optical Job plot was also attained as

described above.
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Chapter VII:

HISTATIN-5 N-TERMINUS RESULTS AND
DISCUSSION

Metal binding to the full length Histatin-5 (Hs-5) was investigated
previously and was able to concretely determine two metal binding sites, the
ATCUN region as well as the copper ion binding domain (HXXXH).97 In the
same study Tay determined that each histatin-5 peptide can bind more than
2 metal ions.97 In analyzing the metal binding to Hs5N the goal was to
determine the stoichiometry of metal binding to the Hs5N fragment using
both optical studies as well as kinetics to determine the redox active species.
Upon addition of CuII to the Hs5N solution a peak at approximately 525 nm
appears. Subsequent addition of CuII increased the intensity of the 525 nm
peak until 2.0 equivalents of CuII. Further addition of CuII shifted the peak
towards the longer wavelengths. This shift is caused by the CuII filling the
second binding site (absorbance around 600nm). This data is displayed in
Figure 7-1. The absorption at 525 (A525) versus concentration of CuII is
shown in Figure 7-2. From Figures 7-1 and 7-2 two valuable pieces of
information are acquired. First, that the N-terminal region of Histatin-5 has
two CuII binding sites. Second, the dissociation constant, Kd, for CuII binding
Hn5N is 6.37 x 10—5 M. The absorbtion maximum at 525 nm is indicative of
a copper center with square planar geometry.98
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Figure 7-1: Optical titration of CuII binding to Hs5N. Optical titration of
CuII with 100 μM Hn5N in 100 mM HEPES pH 7 and 25 °C, which displays
main peak at 525 nm, with shift towards 800 nm after 2 equivalents of
copper ion(relative to Hs-5N). The shift towards 800 nm is likely the result
of increased absorption by the free CuII ion in solution. Each spectra
represents a 0.2 equivalents of CuII from 0-2 equivalents followed by 0.4
equivalents from 2-4.4 equivalents.
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Figure 7-2: CuII binding to Hs5N. Titration of CuII showing saturation of
the A525 binding site when ratio CuII to Hs-5N is 2:1. 100 μM Hn5N, 100
mM HEPES pH7 and 25.0 °C. The A525 was fit to a quadratic equation, thus
1:1 binding with a KD of 6.37 x 10—5 M.
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While the ability of Hs-5N to bind copper is important, more important
is how this copper activates Hs-5N to promote oxidative catalysis. There was
no increase in activity over the uncatalyzed reaction until greater than one
equivalent of copper was added. Considering the flexible stretch of peptide
between the two potential metal binding sites it is possible that with one
copper bound the peptide might fold over the copper ion in such a way as to
prevent the substrate from binding. It is further possible that one CuII center
is simply insufficient for catecholase activity; catecholase activity requires a
two electron transfer and therefore a single CuII to CuI (single electron
transfer) is not enough as seen with tyrosinase. This is a similar
phenomenon that Tay observed.97
The rate at various concentrations of catechol and MBTH while keeping
the Cu2II-Hs-5N complex concentration constant (at 1.0 μM) in 100 mM
HEPES pH 7.0 at 25 °C (Figure 7-4) was tested. This study showed
increased catalytic rate until saturation at higher levels of substrate. The
data displays Michaelis-Menten like steady state kinetics and thus can be well
fitted to the Michaelis-Menten equation:

ν0 =

VMax [CA]
K Hs5 N + [CA]

Where Vo is the observed rate, Vmax is the maximum rate, KHs5N is the
Michaelis-Menten constant, and [CA] is the concentration of substrate, in this
case catechol. This is based upon the assumption that substrate
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Figure 7-3: Activity profile for catechol oxidation with CuII titration.
Equivalents of CuII titrated into 1 μM Hn5N with 1 mM Catechol/MBTH in 100
mM HEPES pH 7.0 and 25 °C.
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concentration is much greater than the complex concentration, i.e.
[catechol]>>[Hs5N- CuII]. Further assumed is that the reaction proceeds
thusly:

[Cu(II)-Hn5] + [CA]

k1

[Cu(II)-Hn5-CA]

kcat

[Cu(II)-Hn5] + o-quinone

k-1

Based upon the data in Figure 7-4, it is possible to determine the KHs5N
to be 3.2 x 10—3 M, the kcat to be 2.20 x 10—2 s—1, and the second order rate
constant (kcat/KM) to be 6.88 M—1 s—1. This represents a 4.6 x 104 rate
enhancement over the autooxidation of catechol (4.74 x 10—7 s—1).
In an effort to better understand the interaction between the metalpeptide complex and the substrate, the slow reacting substrate, DCC, was
utilized in an optical study (Figure 7-5). During this study, DCC was titrated
into the 1.0 mL cuvette that contained 100 μM Complex (2:1) in 100 mM
HEPES pH 7. Upon addition of DCC to the 2:1 complex two new absorption
peaks appears at 306 nm and 426 nm both of which saturate at a 1:1 ratio
DCC to complex. It appears that the Cu2II-Hs-5N complex can bind a single
equivalent of DCC. This finding can be further supported by Figure 7-6 in
which a Job plot is shown.
The Job plot in Figure 7-6 supports the one to one substrate binding
first proposed by the optical DCC titration study shown in Figure 7-5. It
makes sense that the Cu2II-Hs-5N complex can bind just a single substrate
makes sense considering the proposed mechanism of catechol oxidation.
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Since catechol oxidation to o-quinone requires a two-electron transfer, of
which each CuII may contribute one (becoming CuI), and Hs-5N can bind two
copper ions, it seems primed particularly for a single substrate reaction.
Finally, the effect of hydrogen peroxide on the Cu2II-Hs-5N system was
explored. Previous studies have shown that hydrogen peroxide acts as a
second substrate,97 and increases the rate of catechol to o-quinone. Similar
studies were carried out to determine if this second substrate interacts with
the metal center on the N-terminus of Histatin-5. First, an experiment with
increasing concentration of H2O2 (0-32 mM) while holding the concentration
of the 2:1 complex and Catechol/MBTH constant at 1.5 μM and 3.2 mM,
respectively. This demonstrated that saturation of hydrogen peroxide was
possible and thereby implying Michaelis-Menten like steady-state kinetics
(Figure 7-7). The data were fit to the modified Michaelis-Menten equation to
determine the relevant constants:

ν 0 = ν Background +

VMax [H 2O2 ]
K H 2O2 + [H 2O2 ]

The KH2O2 is 5.4 x 10—3 M, a value 1.7 times higher than the KHs5N for
catechol, therefore displaying slightly weaker affinity for hydrogen peroxide
(or a higher kcat). The kcat for H2O2 catalyzed reaction is 4.5 x 10—2 s—1, thus
giving a second order rate constant (kcat/KM) of 8.3 s—1 M—1, an enhancement
of 2.0 and 1.2, respectively, compared to catechol oxidation by Hs-5N
without H2O2.
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Figure 7-4:

Graph of increasing catalytic rate with increasing

substrate concentration until saturation. 1.0 μM Cu2II-Hs-5N complex
in 100 mM HEPES pH 8.0 25 °C. The data is fitted to a the Michaelis-Menten
equation in order to determine rate constants KM, kcat, and kcat/KM.
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Figure 7-5: DCC Binding by Optical Spectroscopy. Optical of DCC
binding studied with 100 μM Cu2II-Hs-5N complex in mixture HEPES and
DMSO (in order to keep DCC soluble). Saturation appears slightly over 1
equivalent DCC. DCC binding was fit to a quadratic equation giving a
dissociation constant of 16 μM.
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Figure 7-6:

Optical Job Plot. Job plot based on change of absorbance at

306 nm as the mol fraction of His5N is varied. Experimental conditions: 0200 μM Hs5N (0-400 μM CuII, i.e. 2:1 complex), 0-200 μM DCC, 100 mM
HEPES pH 7.0 and 25 °C.
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Figure 7-7: Influence of hydrogen peroxide on catechol oxidation.
Catechol oxidation by Cu2II-Hs-5N complex in the presence of varied amounts
of hydrogen peroxide in 100 mM HEPES pH 7. Data display Michaelis-Menten
like kinetics and so is fit to the modified Michaelis-Menten equation, from
which relevant constants KM, kcat, and kcat/KM can be obtained.
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To better elucidate the manner in which the two substrates, hydrogen
peroxide and catechol, influence the binding of the other to the active site,
varying concentrations of catechol were incubated with 1.5 μM Cu2II-Hs-5N
complex with varying concentrations of hydrogen peroxide. This study
provided multiple graphs that showed Michaelis-Menten-like kinetics as a
function of either [Catechol] or [H2O2] (as shown in Figure 7-8).
Furthermore, a second graph can be attained from the same data, that is a .
The basic Michaelis-Menten equation, as stated above, can be replotted in a
linear relationship in accordance with the Hanes-Woolf plot:
App
⎛
⎞
K Catechol
⎜1 +
⎟
K HApp
[H 2 O2 ] ⎜⎝ [Catechol ] ⎟⎠ [
2 O2
=
H 2 O2 ] +
ν0
V max
V max

Int
⎛
⎞
K Catechol
⎜1 +
⎟
⎜ [Catechol ] ⎟
⎝
⎠

From which two secondary plots may be attained, one which relates the yintersect of all the lines on Figure 7-9 part A to the inverse of the catechol
concentration (Figure 7-9 part B) and another which relates the slopes of the
same lines to the inverse of the catechol concentration (Figure 7-9 part C).
From combining data represented on these graphs the various affinity
constants may be ascertained, which are depicted in Table 1, as well as a
comparison to the affinity constants in previous studies.99

y − int =

K HApp
2 O2
Vmax

Int
⎛ K HApp
O2 K Catechol
2
+⎜
⎜
Vmax
⎝

⎞
1
⎟
⎟ [Catechol]
⎠
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Figure 7-8: Catechol oxidation by various concentrations of catechol
and various concentrations of hydrogen peroxide. 1.5 μM complex
(2:1) with varying amounts of catechol (0-6.0 mM) and hydrogen peroxide
(0-32 mM) in 100 mM HEPES pH 8.0. The graph clearly shows saturation of
hydrogen peroxide above 16mM. From this data the Hanes-Woolf plot shown
in Figure 6-9 is accomplished.
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Figure 7-9: Hanes-Woolf Analysis. Hanes analysis of the oxidation of
catechol by Cu2II-Hs-5N complex in the presence of varied amounts of
hydrogen peroxide based upon data presented in Figure 7-8. The smaller
submissive plots below are a replot of the various data represented in the
larger dominatrix plot above. From which the values in Table 1 were
gathered.
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There are a few interesting things to note based on the data presented
in Table 1. First, the kcat for the catechol oxidation reaction with H2O2 shows
a 1.97 x 105 fold enhancement versus the autooxidation reaction. Second,
the apparent KH2O2 is 33 % higher than the intrinsic KH2O2 while the apparent
Kcatechol is nearly unchanged than the intrinsic Kcatechol. This indicates that the
binding of H2O2 has no effect on the binding of catechol, while the binding of
catechol slightly inhibits or blocks the binding of H2O2. Third, in essence this
is similar to the results previously shown99 for the full length peptide, the
only difference is the degree to which the apparent KH2O2 is lowered relative
to the intrinsic value. This indicates that the catalytically relevant region of
the peptide, in so much as the activity in which we are measuring, may
largely take place in the N-terminus, and not in the C-terminus.
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Constant

Histatin-5 N terminus

Histatin-5 Full length97

kcat with H2O2

9.33 x 10—2 s—1

Not reported

Apparent KH2O2

4.21 x 10—3 M

5.23 × 10—3 M

Intrinsic KH2O2

3.16 x 10—3 M

2.26 x 10—3 M

Apparent KCatechol

3.42 x 10—3 M

3.63 x 10—3 M

Intrinsic KCatechol

3.55 x 10—3 M

3.06 x 10—3 M

Table 7-1: Comparison of Hs-5N to full length Hs-5. The valuable affinity
constants and catalytic rate constants ascertained from the Hanes-Woolf Plot
compared to the ones collected by Dr. William Tay for the full length
peptide.97

100

Chapter IIX:

HISTATIN-5 N-TERMINUS CONCLUSION

This study focused essentially on reducing the metal binding sites in
the Histatin-5 peptide system which is well known for antimicrobial activity,
candidacidal and bactericidal. The aim of this was to determine whether the
amino terminus of Hs-5 showed the oxidative activity of the full length
peptide. In many ways, it mirrored the study done by Dr. Tay,97 but the goal
was to determine what truly is active in histatin-5. As was discussed earlier,
the primary sequence of histatin-5 shows many sites which might bind metal
and therefore be vital for the oxidation activity displayed by histatin-5.
Bisecting the sequence effectively halves the metal binding sites to two sites,
the ATCUN region and the HHGY sequence (the most likely candidate
knowing that Hs5N binds two metals, one of which we know is the ATCUN
region). From the data presented, there can be no doubt that the Nterminus has the ability to bind CuII, a redox-active metal, and the substrate
(catechol), but furthermore shows similar affinity constants, as well as kinetic
parameters (kcat and kcat/KM) and peroxide influences (Table 7-1) of the full
length peptide. With this in mind, it is reasonable to say that the N-terminus
is responsible for the oxidative activity seen in the full length peptide. It is
impressive to see such a small and simple system that is able to perform
such complex chemistry attaining a 1.97 x 105-fold rate enhancement.
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Appendix A:

Pertinent information and Protocols regarding
SgAP project using E. coli expression system

A-1:

Streptomyces griseus aminopeptidase (SgAP) nucleotide
sequence:
GGTACCGCCC
TGCTGCGGGC
CTGGCCCGCT
GGGGCGCCGG
CGCTCTTGAC
CCGCTTGTCG
GCACGTTCCG
CCTGCGCAGA
TGCCCCGGCC
CGACATCCCC
CAACGGCGGC
GGCCAAGCTC
CACCGGCTAC
CGGGGCCCAC
GGCCGCCGTG
CCTGCGGTTC
CAACAACCTG
CGGCTCGCCC
CAAGGACTAC
CTCCGACCAC
CGGCTACACC
CGACCGCTGC
CCGCAACAGC
GCCCACCGGC
CGCGG

GGACGGCCCG
CCTGCGCCCG
CCGCCGGTCG
GGTTCACGGG
GGAGCACTGT
GGCCCACGCT
TCAGTCCCCA
TCCCCGACGG
GCCCAGGCCG
CTGGCCAACG
AACCGCGCCC
GACGCGGCCG
AACCTGATAG
CTCGACTCGG
CTGGAGACCG
GCCTGGTGGG
CCGTCCGCCG
AACCCCGGTT
TTCGCCGGCC
GCCCCGTTCA
AAGTCCGCCG
TACCACTCCT
GACGCCGCCG
GAGGGCGTCT

CTCAGCCGCC
TAGCGGGGGT
GGGTGAGTCT
CGAACCACTG
CATTTCCTTG
CCAGGACCCG
ACGGAATCCG
CCGTCGCCGC
CCGGCGCCGC
TCAAGGCCCA
ACGGCCGCCC
GATACACCAC
CCGACTGGCC
TCTCCTCCGG
CGCTCGCCGT
GCGCGGAGGA
ACCGCTCCAA
ACTTCGTCTA
TGAACGTCCC
AGAACGTCGG
CCCAGGCGCA
CGTGCGACAG
CCCACGCGAT
TCAGCAACAC
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AGGAGGTCGC
ACGGGGCCGG
GGATACATGA
TTCGTTAATA
AGCATCGGTC
GCCGGATCAC
GAGCCCGTGA
CGTGGCCCTC
GGCCCCGACG
CCTCACGCAG
CGGCTACAAG
CACGCTCCAG
CGGCGGCGAC
CGCCGGGATC
CTCCCGCGCC
GCTGGGCCTG
GCTCGCCGGA
CGACGACGAC
GACCGAGATC
CGTCCCCGTC
GAAGTGGGGC
CCTGAGCAAC
CTGGACCCTG
CACGGACGTG

CGACCACCTC
CCGGCGGATC
CGTATGTCCT
GAACGGCTAT
ACGCATTGCG
CGCGCGGCCG
ATGAGACCGA
GCCGCCGTCC
GCAGCCGCCG
CTCTCGACGA
GCGTCCGTCG
CAGTTCACCT
CCCAACAAGG
AACGACAACG
GGGTACCAGC
ATCGGCTCGA
TATCTCAACT
CCGGTCATCG
GAGACCGAGG
GGCGGACTCT
GGGACGGCCG
ATCAACGACA
TCCTCCGGCA
GCCATCCCGG

GCGGACCTGC
TCGCTACCCA
GCCTCCCGAT
GTCCGGTTTC
CACCTCTGGG
GGGACCCCCC
ACCGCTTCTC
TCGCGGCCGG
CGGCCGCGCC
TCGCCGCGAA
ACTACGTGAA
CGGGCGGGGC
TCCTGATGGC
GCTCCGGCTC
CCGACAAGCA
AGTACTACGT
TCGACATGAT
AGAAGACCTT
GCGACGGCCG
TCACCGGCGC
GGCAGGCCTT
CCGCCCTGGA
CCGGCGAACC
ACGCCGGGGC

Appendix A (Continued)
A-2:

Translated active SgAP aligned with translated active ScAP

SgAP
ScAP

APDIPLANVKAHLTQLSTIAANNGGNRAHGRPGYKASVDYVKAKLDAAGYTTTLQQFTSG
APDIPIANVKAHLRQLESIATANGGNRAHGRAGYRASLDYMKAKLDAAGFTTRVQQFSAS
*****:******* **.:**: *********.**:**:**:********:** :***::.

SgAP
ScAP

GATGYNLIADWPGGDPNKVLMAGAHLDSVSSGAGINDNGSGSAAVLETALAVSRAGYQPD
GRTGYNLTADWPGGDASQIVMAGSHLDSVASGPGINDNGSGSSAVLETALAVARSGYQPT
* ***** *******..:::***:*****:**.*********:*********:*:****

SgAP
ScAP

KHLRFAWWGAEELGLIGSKYYVNNLPSADRSKLAGYLNFDMIGSPNPGYFVYDDDPVIEK
KHLRFAWWGAEELGLVGSRYYVNSLGSAERAKISGYLNFDMIGSPNPGYFVYDDDPTIEK
***************:**:****.* **:*:*::**********************.***

SgAP
ScAP

TFKDYFAGLNVPTEIETEGDGRSDHAPFKNVGVPVGGLFTGAGYTKSAAQAQKWGGTAGQ
TFKDYFSGIGISTEIETEGDGRSDHAPFKNAGVPVGGLFSGADYRKTSAQAAKWGGTVGQ
******:*:.:.******************.********:**.* *::*** *****.**

SgAP
ScAP

AFDRCYHSSCDSLSNINDTALDRNSDAAAHAIWTLSSGTGEPPTGEGVFSNTTDVAIPDA
PFDRCYHSSCDTTANIDDTALDRNSDAIAYAVWELSQ----------------------.**********: :**:********** *:*:* **.

SgAP
ScAP

GAA
---

*=Identical; :=conserved substitution; .=semi-conserved substitution
A-3: Streptomyces coelicolor Aminopeptidase (ScAP) Nucleotide
Sequence
CTACTGCGAC
GTCGTCGATG
CACGGTGCCG
GAGGCCGCCC
CTCGGTCTCG
GATCGTGGGA
GTTCAGGTAA
GGAGCCGACG
CTGGTAGCCG
GTTGTCGTTG
CTGACTCGCG
GCTGAACTGC
GAGGGAGGCC
CGACTCCAGC
GGCAGCGGCA
GGAACCGCCG
AGGGAGGAGC

AGTTCCCAGA
TTGGCGGTCG
CCCCACTTGG
ACGGGGACGC
ATCTCCGTGG
TCGTCGTCGT
CCGCTGATCT
AGTCCCAGCT
GACCGGGCGA
ATGCCGGGCC
TCGCCGCCGG
TGGACGCGGG
CGGTAGCCGG
TGCCTCAGAT
GTGCCGGTGG
GCCATCAGTG
TGCAT

CCGCGTAGGC
TGTCGCAGGA
CCGCCTGCGC
CCGCGTTCTT
AGATGCCGAT
AGACGAAATA
TCGCGCGTTC
CCTCCGCGCC
CGGCGAGCGC
CGGAGGCGAC
GCCAGTCGGC
TGGTGAACCC
CGCGGCCGTG
GGGCCTTGAC
GGGTGGCGGG
TGACGACGGC

GATGGCGTCG
CGAGTGGTAG
GGACGTCTTG
GAAGGGTGCG
CCCGCTGAAG
GCCGGGGTTG
CGCGGAGCCG
CCACCAGGCG
GGTCTCCAGG
ACTGTCCAGA
CGTCAGGTTG
GGCGGCGTCC
GGCGCGGTTG
GTTGGCTATC
GTGCACGGGC
GACGGCTCCG

CTGTTGCGGT
CAGCGGTCGA
CGGTAGTCCG
TGGTCGGAGC
TAGTCCTTGA
GGCGAGCCGA
AGGCTGTTGA
AAGCGCAGGT
ACGGCCGAGG
TGTGACCCGG
TACCCGGTGC
AGCTTGGCCT
CCGCCGTTCG
GGTATGTCGG
GCGGACGCCG
GCCGTCAGTG

Highlighted regions correspond to PCR primer binding sites.
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CCAGGGCCGT
AGGGCTGGCC
CGCCGCTGAA
GTCCGTCGCC
ACGTCTTCTC
TCATGTCGAA
CGTAGTAGCG
GCTTCGTCGG
AGCCGGAACC
CCATGACAAT
GGCCCGAGGC
TCATGTAGTC
CCGTGGCGAT
GCGCGGCGGC
CACCGGCGGC
CGCGCCCGGA

Appendix A (Continued)
PCR Protocol for obtaining insert from S. coelicolor genomic DNA
Master Mix (for single sample) *Done in PCR hood
1) Nano pure Water

28.0μL

2) 5x Taq Master

10.0μL (must first be thawed 15min at 65°C)

3) 10x Taq Buffer

5.00μL

4) 10.0mM dNTP

1.00μL

5) 5’-primer

0.50μL

(stock solution 55.1μM)

6) 3’-primer

0.50μL

(stock solution 40.4μM)

7) Taq Polymerase

0.50μL

PCR Sample Tubes

*Done in PCR Hood

1) Master Mix

46.5μL

2) Nano pure Water

1.50μL

3) Mg2+

1.00μL

4) Genomic DNA

1.00μL *Not added in PCR Hood (Need to

find concentration of this)
PCR Cycles
1) Hold at 95°C for 3.5 minutes
2) Heat to 95°C for 30 seconds
3) Cool to 50°C and hold for 30 seconds
4) Heat to 72°C and hold for 1.5 minutes
120

Appendix A (Continued)
5) Repeat steps 2-4 for a total of 35 cycles
6) Hold at 72°C for 10minutes
7) Cool to 4°C until removed and stored for future use
Purifying DNA using Amicon Spin Columns
1) Place spin column on tube.
2) Add 300μL nano pure water into reservoir
a. Adjust based on sample but no less than 300, so total
volume is 400μL
3) Add no more than 100μL sample reaction to reservoir
4) Place assembled device into centrifuge with cap strap inward
5) Centrifuge at 1000xg for 15 minutes
6) Remove from centrifuge , save filtrate until sample has been
analyzed
7) Place reservoir upright into clean vial. Add 20μL TE.
8) Invert reservoir into the clean vial and centrifuge at 1000xg for 2
minutes.
9) The sample should now be pure and ready for downstream
applications
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A-4: pQE-30 Xa Vector Map from “The Qiaexpressionist”
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Restriction Digest Protocol
Vector Digest
Add to 0.65mL Eppendorf Tube:
1) Nano Pure Water

67.0μL

2) pQE-30 Xa

20.0μL (Stock Solution at 189ng/μL)

3) Buffer B

10.0μL

4) BSA

2.00μL

5) XmaI

0.50μL

Then:
1) Place in 37°C Water bath for 6.0 hours
2) Add 0.50μL StuI
3) Return to 37°C Water bath for 16.0 hours
4) Purify product using Amicon Spin Columns (see above)
Insert Digest
Add to 0.65mL Eppendorf Tube:
1) Nano Pure Water

33.0μL

2) Insert DNA

10.0μL

3) Buffer B

5.00μL
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4) BSA

1.00μL

5) XmaI

1.0μL

Then:
1) Incubate at 37°C for 6 hours
2) Purify using Amicon Spin Columns (See Above)
Ligation Protocol
Ligation Buffer:
1) Nano Pure Water

22.5μL

2) 1.0M Tris pH 7.5

50.0μL

3) 1.0M DTT

10.0μL

4) 100mM ATP

10.0μL

5) MgCl2

5.00μL

6) BSA

2.50μL

Reaction Tubes:
1) Nano Pure Water

24.9μL

2) Ligation Buffer

3.00μL

3) Ligase

1.00μL
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4) Insert

2.57μL (Concentration 202.5ng/μL)

5) Vector

0.50μL (Concentration 202.5ng/μL)

This creates a 20:1 ratio, 20 inserts per vector
Then:
1) Hold at 17.0°C for 14-18 hours
2) Proceed to Transformation without purification
Transformation Protocols
XL1-Blue Transformation
1) Thaw glycerol stocks of cell line (stored at -80°C) on Ice
2) Place 1.5mL eppendorf tubes on ice to pre-chill
3) Add 80μL XL1-Blue to 1.5mL Eppendorf tube
4) Add 2.00μL ligation reaction product
5) Mix well by flicking or brief vortexing
6) Hold on ice for 30.0 minutes
7) Heat shock at 42°C for 45 seconds
8) Replace in ice for 2.0 minutes
9) Pipette 41.0μL onto agar plate with antibiotics (Ampicilin at
100μg/mL)
a. Two plates per transformation
10)

Grow at 37°C for approximately 24 hours
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Rosetta Blue Transformation and BL21 Transformation
1) Thaw glycerol stocks of cell line (stored at -80°C) on Ice
2) Place 1.5mL eppendorf tubes on ice to pre-chill
3) Add 20.0μL Rosetta Blue thawed cells to 1.5mL Eppendorf tube
4) Add 1.00μL ligation reaction product
5) Mix well by flicking or brief vortexing
6) Heat shock at 42°C for 45 seconds
7) Incubate on Ice for 2.0 minutes
8) Add 80.0μL room temperature SOC medium
9) Shake at 250rpm, 37°C for 1 hour
10)

Dilute transformation into more SOC medium
a. 10μL transformation with 30μL SOC, total volume of 40μL
b. 20μL transformation with 20μL SOC, total volume of 40μL

11)

Spread onto LB-AMP agar plates and incubate at 37°C for

approximately 24 hours
3mL overnight culture protocol
1) Add 3mL LB-AMP (100μg/mL) broth to sterilized test tube
2) Pick single colony off agar plate using sterilized toothpick
3) Add toothpick to 3mL LB-AMP broth in test tube
4) Shake in incubator at 300rpm, 37°C for 16-18 hours (overnight)
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Crude Mini Prep Protocol
1) Centrifuge 1.0-1.5mL of 3.0mL overnight culture at 14,000xg for
1.0 minute
2) Decant supernatant, remove residual supernatant with pipette
3) Add 150μL Buffer P1 (with RNase A). Resuspend by vortexing
4) Add 150μL Buffer P2. Invert to mix. Hold at room temperature 5.0
minutes
5) Add 150μL Buffer P3. Invert to mix. Hold on Ice 5.0 minutes
6) Centrifuge at 14,000xg, 4°C for 10.0 minutes
7) Add supernatant to 1.0mL ethanol (100%). Incubate -80°C for 1
hour
8) Centrifuge at 14,000xg, 4°C for 15.0 minutes
9) Decant supernatant. Wash pellet with 200μL 70% ethanol
10)

Centrifuge at 14,000xg for 5.0 minutes

11)

Decant 70% ethanol supernatant and air dry pellet

12)

Add 30μL TE and dissolve pellet

Perfect Mini Prep Protocol
1) Centrifuge 1.0-1.5mL of 3.0mL overnight culture at 14,000xg for
1.0 minute
2) Decant supernatant, remove residual supernatant with pipette
3) Add 100μL Solution 1 to the cell pellet. Resuspend by vortexing
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4) Add 100μL Solution 2. Invert to mix.
5) Add 100μL Solution 3. Invert to mix.
6) Centrifuge at 14,000xg for 30 seconds. Transfer supernatant to
spin column.
7) Vigorously and thoroughly mix the DNA binding matrix suspension
before pipetting.
8) Add 450μL DNA binding matrix to the supernatant in the spin
column. Mix by capping the spin column and inverting vigorously
9) Centrifuge the spin column assembly at 14,000xg for 30 seconds.
Decant filtrate and replace spin column into the collection tube.
10)

Add 400μL DILUTED purification solution to same spin column.

Cap the tube, shake briefly and centrifuge at 14,000xg for 60
seconds
11)

Decant filtrate and place spin column back into collection tube.

Centrifuge at 14,000xg for 60 seconds to remove residual
Purification solution.
12)

Transfer spin column to fresh collection tube. Add 50-70μL of

Elution Buffer directly to the DNA binding matrix in the spin
column. Cap the assembly and vortex briefly.
13)

Centrifuge at 14,000xg for 60 seconds.
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14)

Discard spin column and cap the collection tube. Eluted plasma

DNA is ready for downstream applications or can be stored at 20°C.
Agarose Gel Electrophoresis
Preparing the Gel (0.7%)
Add to microwave safe Erlenmeyer Flask
1) 1X TAE

50mL (Volume Varies by gel rig)

2) Agarose 0.35g (depends on gel percentage)
a.
3) Swirl to Mix
4) Microwave on High for 15 second intervals, swirling between
intervals, until all agarose has dissolved.
5) Let cool 1-2 minutes, add 20μL ethidium bromide
6) Pour into gel rig, with comb, and let rest until polymerization is
complete
Running Conditions (general, may be adjusted as needed by samples)
1) 150 Volts
2) 35 minutes
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Overexpression protocol
1) To sterilized Erlenmeyer flask (250mL for this example) add 99mL
Fresh LB-AMP (100μg/mL) broth
2) Add 1.0mL of 3.0mL overnight culture to 100mL Fresh LB-AMP
3) Shake in incubator at 300rpm, 37°C until OD=0.4-0.6, use 1.0mL
Fresh LB-AMP to blank spectrophotometer.
a. While growing make IPTG solution.
b. Add 0.024g IPTG to 3.0mL LB-AMP broth, invert to dissolve
i. Makes 3mL of 33.6mM solution
4) Take “uninduced” sample, 1.0mL. Centrifuge at 14,000xg for 1.0
minute, remove supernatant and re-suspend pellet in 50μL SDSPAGE loading buffer.
a. Put sample in boiling water bath for 5-7 minutes
5) Add IPTG solution, so final concentration is 1mM
a. Based on above, add 3mL IPTG solution to 98mL culture
(99mL (Fresh LB-AMP)+1.0mL (Overnight Culture) -1.0mL
(to test OD)-1.0mL (for uninduced sample)
b. Optional to take time point samples at 1, 2, 3, 4 etc. hours
6) Centrifuge remainder at 10,000xg for 20min to pellet cells.
7) Store in -20°C until ready for use for purification
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Purification of ScAP under denaturing (for insoluble fraction)
conditions
1) Thaw cells on Ice for 15.0-20.0 minutes
2) Re-suspend pellet in 15mL bacterial cell wall lysis buffer (for a
100mL overexpression sample) by vortexing or pipetting.
a. 2-5mL cell wall lysis buffer per gram wet pellet weight
3) Add 1.7 mg lysozyme per mL of cell wall lysis buffer
a. Optional to add protease inhibitors:
i. 250μL 10mM PMSF
ii. 250μL 10mM Benzamidine
4) Shake on ice for 60.0 minutes
5) Sonicate 60 seconds, take sample for SDS-PAGE
6) Pellet cells at 10,000xg, 4°C, 20 minutes.
a. Save supernatant for SDS-PAGE
7) Add 15mL Urea buffer to cell pellet and resuspend.
a. Take sample for SDS-PAGE
8) Incubate 1.0 hour at 37°C shaking at 200rpm. Take sample for
a. SDS-PAGE
9) Centrifuge at 10,000xg, 4°C, 20 minutes
10)

Add 1mL Ni-NTA Agarose, shake on ice 45.0 minutes
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11)

Add to column and collect flow through.
a. Take sample for SDS-PAGE

12)

Wash 2x 4mL with Buffer C (pH 6.3)
a. Take sample for SDS-PAGE

13)

Elute with 2mL Buffer D (pH 5.9)
a. Take sample for SDS-PAGE

14)

Elute with 2mL Buffer E (pH 4.5)
a. Take sample for SDS-PAGE

15)

Run samples from above on SDS-PAGE. Purpose:
a. Find target protein and Determine which elution fraction has
bulk of target protein
b. Ensure purification is working properly
c. Determine if any modifications need to be made.

16)

Optional modifications include
a.

adjust the volumes for washing or eluting.

b. More or less Ni-NTA Agarose
c. Adjusting volume of Urea Buffer
d. Replacing Urea Buffer with Guandine Buffer
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Purification of ScAP insoluble fraction using Detergents to denature
1) Thaw cells on Ice for 15.0-20.0 minutes
2) Re-suspend pellet in 15mL bacterial cell wall lysis buffer (for a
100mL overexpression sample) by vortexing or pipetting.
a. 2-5mL cell wall lysis buffer per gram wet pellet weight
3) Add 1.7 mg lysozyme per mL of cell wall lysis buffer
a. Optional to add protease inhibitors:
i. 250μL 10mM PMSF
ii. 250μL 10mM Benzamidine
4) Shake on ice for 60.0 minutes
5) Sonicate 60 seconds, take sample for SDS-PAGE
6) Pellet cells at 10,000xg, 4°C, 20 minutes.
a. Save supernatant for SDS-PAGE
7) Resuspend pellet in 10mL Cell Wall Lysis Buffer (no lysozyme) with
30μL Tween-20 (0.3%)
a. Also tried .1% Tween-20
8) Add Stir bar and stir vigorously in fridge for 4 hours
9) Add 5 grams SM-2 Bio-Beads and stir in fridge overnight
10)

Centrifuge at 10,000xg, 4°C for 20 minutes
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Another Purification protocol using detergents to denature
1) Thaw cells on Ice for 15.0-20.0 minutes
2) Re-suspend pellet in 15mL bacterial cell wall lysis buffer (for a 100mL
overexpression sample) by vortexing or pipetting.
a. 2-5mL cell wall lysis buffer per gram wet pellet weight
3) Add 1.7 mg lysozyme per mL of cell wall lysis buffer
a. Optional to add protease inhibitors:
i. 250μL 10mM PMSF
ii. 250μL 10mM Benzamidine
4) Shake on ice for 60.0 minutes
5) Sonicate 60 seconds, take sample for SDS-PAGE
6) Pellet cells at 10,000xg, 4°C, 20 minutes.
a. Save supernatant for SDS-PAGE
7) Resuspend pellet in 10mL Cell Wall Lysis Buffer (no lysozyme) with
30μL Tween-20 (0.3%)
a. Also tried .1% Tween-20
8) Add Stir bar and stir vigorously in fridge for 4 hours
9) Add 5 grams SM-2 Bio-Beads and stir in fridge overnight
10)

Remove liquid with as few biobeads as possible and run through

column to remove remaining biobeads
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11)

Add 1mL Ni-NTA Agarose to flow through and shake on ice for

45.0 minutes
12)

Add to column collect flow through, wash and elute as for

soluble fraction (see below)
Purification of ScAP under native (soluble fraction) conditions
1) Thaw cells on Ice for 15.0-20.0 minutes
2) Re-suspend pellet in 15mL bacterial cell wall lysis buffer (for a
100mL overexpression sample) by vortexing or pipetting.
a. 2-5mL cell wall lysis buffer per gram wet pellet weight
3) Add 1.7 mg lysozyme per mL of cell wall lysis buffer
a. Optional to add protease inhibitors:
i. 250μL 10mM PMSF
ii. 250μL 10mM Benzamidine
4) Shake on ice for 60.0 minutes
5) Sonicate 60 seconds
a. Take sample for SDS-PAGE
6) Pellet cells at 10,000xg, 4°C, 20 minutes.
7) Supernatant is soluble protein fraction.
a. Take sample for SDS-PAGE
8) Add 1.0 mL Ni-NTA agarose to supernatant in Erlenmeyer flask.
9) Shake on Ice for 45.0 minutes
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10)

Add to column and collect flow through
a. Take sample for SDS-PAGE

11)

Wash 2x4mL with Wash buffer
a. Take sample for SDS-PAGE

12)

Elute 4x0.5mL with Elute buffer
a. Take Sample for SDS-PAGE

13)

Run SDS-PAGE

14)

Optional modifications include
a.

adjusting the volumes for washing or eluting.

b. More or less Ni-NTA Agarose
Cell Wall Lysis Buffer
1) 50.0mM NaH2PO4
2) 1.0M NaCl
3) 10.0mM imidazole
4) pH 8.0
Urea Buffer (insoluble fraction)
1) 8M Urea
2) 100mM NaH2PO4
3) Triton X-100 (500μL per 50mL total volume)
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4) 10.0mM Tris pH 8.
5) Adjust pH to 8 using NaOH
Guanidine Buffer (insoluble fraction)
1) 6M Guanidine
2) 100.0mM NaH2PO4
3) 10.0mM Tris
4) Adjust pH to 8.0
Buffers C, D, and E (insoluble fraction)
1) 100mM NaH2PO4
2) 10mM Tris-CL
3) 8M Urea (6M Guanidine can be substituted)
a. Buffer C pH adjusted to 6.3
b. Buffer D pH adjusted to 5.9
c. Buffer E pH adjusted to 4.5
Wash Buffer (soluble fraction)
1) 50mM NaH2PO4
2) 300mM NaCl
3) 20mM imidazole
4) Adjust pH to 8.0 using NaOH

137

Appendix A (Continued)
Elution Buffer (soluble fraction)
1) 50mM NaH2PO4
2) 300mM NaCl
3) 250mM imidazole
4) Adjust pH to 8.0 using NaOH
Protein Refolding for insoluble fraction after purification
Protocol Basic Refolding protocol
1) Add appropriate fraction (based on SDS-PAGE) into dialysis bag
2) Place dialysis bag (Approximately 2mL) in 150mL beaker with
Dialysis Buffer
a. 50.0mM Tris
b. 100.0mM NaCl
c. Adjust pH to 8.0
d. Possible modifications
i. 50mM Glycine
ii. 2mM Beta-mercaptoethanol
iii. Also substituted 50.0mM Tris with 100mM HEPES
3) Change buffer 4 times with at least 4 hours in between changes
4) Potential modifications
a. Adding 50μM ZnCl2
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b. Adding 1mM CaCl2
c. pH 7.5
d. Diluting the appropriate fraction
i. Ex. 1mL Fraction E + 39mL fresh Buffer E placed into
dialysis bag and dialyzed against Dialysis buffer (note
that this requires a larger beaker for dialysis and
therefore more dialysis buffer
ii. Also tried 2mL Fraction E +198mL Buffer E
iii. The goal of this was to prevent the protein from
precipitating with the fast removal of denaturant (Urea
or Guanidine
e. Use a stepwise removal of denaturant
i. Dialysis buffer one contains 6M urea,
ii. Dialysis buffer two contains 3M urea,
iii. Dialysis buffer three contains 1M Urea
iv. Dialysis buffer four contains no urea, etc.
Renaturation Protocol
1) Dilute 2mL Buffer E into 98mL Renaturation Buffer
a. 20mM Tris
b. 100mM NaCl
c. pH 8.0
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2) Shake on Ice 30.0 min
3) Add 1mL Ni-NTA Agarose
4) Shake on Ice 30.0 min
5) Add to column and collect flow through
6) Elute with 2mL Elution buffer (Same as for soluble fraction
purification “Elution Buffer” see above)
7) Dialyzed against 2x250mL Buffer
a. 20mM Tris
b. 100mM NaCl
c. 50μM ZnCl2
d. 1mM CaCl2
e. pH 8
Modified Renaturation Protocol
1) Instead of eluting insoluble fraction from column with Elution
Buffer, add 5-10mL acetone/Guanidine buffer but do not run
through column.
a. 1.4M Acetone
b. 0.7M Guanidine
c. 1mM CaCl2
d. 50μM ZnCl2
e. pH 8.5

140

Appendix A (Continued)
2) Swirl or pipette up and down to suspend His-tagged protein-Ni-NTA
Agarose complex into the acetone/Guanidine buffer and remove
from column.
3) Add to 40-45mL acetone/Guanidine buffer (total volume approx.
50mL)
4) Shake at 150rpm, 35°C for 1.0 hour
5) Add back to column and collect flow through
6) Elute from column with 2mL Elution Buffer (Same as for soluble
fraction purification “Elution Buffer” see above)
7) Dialyze against 2x250mL Buffer
a. 20mM Tris
b. 100mM NaCl
c. 50μM ZnCl2
d. 1mM CaCl2
e. pH 8
Another renaturation attempt
1) Elute from column with Buffer E as stated in insoluble fraction
purification protocol
2) Refold in Acetone/Guanidine buffer, shake at 150rpm, 35°C for 1.0
hour
3) Add 1mL Ni-NTA Agarose, shake on ice for 45.0 minutes
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4) Add to column, collect flow through
5) Elute with 2mL Elution buffer (Same as for soluble fraction
purification “Elution Buffer” see above)
Western Blotting Protocol
1) Perform SDS-PAGE, 150 volts for 1.5 hours
2) Equilibrate Membrane
a. 3 seconds Methanol,
b. 1-2 minutes H2O,
c. 5-10 minutes western transfer buffer
3) Equilibrate Gel
a. 5 minutes H2O
b. 10 minutes western transfer buffer
4) Soak pad and paper for transfer in western transfer buffer
5) Assemble western transfer apparatus:
a. Black side
b. Pad
c. Paper
d. Gel
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e. Membrane
f. Paper
g. Pad
h. Clear
6) Run in apparatus with ice pack and stir bar, 1.0 hour and 100 volts
7) Soak in 200mL 1X-PBS blotto at room temp for 1.0 hour
8) Soak in 10mL blotto, .5% Tween-20 and 40000-fold dilution of primary
antibody
a. Primary antibody is RGS-His from Qiagen
9) Wash 3x 30 minutes in 600mL Blotto
10)

Soak in 9mL Maleic Acid Buffer + 1mL 10X blocking reagent

with 5μL secondary antibody
a. Secondary antibody___
11)

Wash 3x 30 minutes with 600mL Maleic Acid buffer with 0.3%

Tween-20
12)

Add to bag with 1mL BM Purple in dark and soak for 10 minutes

13)

Remove from bag and rinse with nano pure H2O

143

Appendix A (Continued)
SDS-PAGE Running Buffer
1) 3g Tris
2) 14.4 g Glycine
3) 10mL 10% SDS
4) Add H2O to 1L
Western Transfer Buffer
1) 6.0g Tris
2) 14.4g Glycine
3) 200mL Methanol
4) Add H2O to 1L
Maleic Acid Buffer
1) 100mM Maleic Acid
2) 150mM NaCl
3) pH to 7.5
4) Autoclave 15 minutes at 121°C
1X-PBS Blotto (1 liter)
1) 100mL 10X phosphate buffer saline
2) 50 grams nonfat dry milk (5%)
3) Add H2O to 1L
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Appendix B: Pertinent information and Protocols regarding SgAP
project using S. lividans expression system
B-1: Modified ScAP nucleotide sequence as synthesized by Genscript.
CCATGGATGCGCATCAAGCGGACCTCCAACCGCAGCAACGCCGCGCGCCGAGTCCGCACCACGGCGGTC
CTGGCGGGACTCGCAGCAGTGGCAGCATTGACCGCCCCCACCCCGGCGGCGGCGGCGGCACCGGACAT
CCCGATCGCGAACGTCAAGGCCCACCTCCGGCAGCTCGAGAGCATCGCGACCGCCAACGGAGGCAACCG
GGCCCACGGCCGTGCGGGTTACCGGGCCTCGCTCGACTACATGAAGGCGAAGCTGGACGCCGCCGGCTT
CACGACTCGTGTGCAGCAGTTTAGCGCGTCGGGCCGTACCGGGTACAACCTGACCGCCGACTGGCCCGG
CGGCGACGCGTCCCAGATCGTGATGGCCGGGAGCCACCTCGACTCGGTGGCTTCCGGCCCCGGTATCAA
CGACAACGGCTCCGGCAGTAGCGCCGTCCTGGAGACGGCGCTGGCGGTCGCCCGATCGGGTTACCAGC
CGACCAAGCACCTCCGGTTCGCCTGGTGGGGCGCGGAGGAGCTGGGCCTGGTCGGCTCCCGGTACTAC
GTCAACTCGCTGGGCAGCGCCGAGCGCGCCAAGATCAGCGGGTACCTGAACTTCGACATGATCGGCTCC
CCGAACCCGGGTTACTTCGTCTACGACGACGACCCGACGATCGAGAAGACCTTCAAGGACTACTTCTCCG
GGATCGGCATCTCCACGGAGATCGAGACCGAGGGCGACGGACGCTCCGACCACGCACCCTTCAAGAAC
GCGGGAGTCCCGGTCGGCGGCCTGTTCAGCGGCGCCGACTACCGCAAGACCTCCGCGCAGGCGGCCAA
GTGGGGCGGCACTGTCGGCCAGCCCTTCGACCGCTGCTACCACTCCAGTTGCGACACCACGGCCAACATC
GATGACACGGCCCTGGACCGTAACAGCGACGCCATCGCATACGCCGTCTGGGAGCTGTCGCAGATCGAG
GGCCGGCATCACCACCACCACCACGGTACC
Yellow highlight corresponds to Engineered restriction site for NcoI
Green highlight corresponds to signal peptide from Streptomyces
griseus PB
Cyan highlight corresponds to signal peptide from Alpha Amylase
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B-2: pUC57 Vector Map (contains Insert)
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B-3: pD730 Vector Map
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Restriction Digest Protocol
pD730 Digest
For One Sample (ie volumes can be multiplied accordingly, time
adjusted as needed but not a multiple of the ingredients)
1) Add to 0.65mL Eppendorf Tube
a. Nano pure H2O

2.7μL

b. Multicore Buffer

1.5μL

c. BSA

0.5μL

d. SacI

0.3μL

e. pD730 Vector DNA

10.0μL

2) Place in 37°C water bath for 4 hours or overnight
3) Briefly centrifuge to bring condensation down off tube walls and lid
4) Add 0.3μL NcoI
5) Return to 37°C water bath for 20 min
6) Heat inactivate NcoI by placing in 65°C water bath for 15.0 min
7) Run on Agarose Gel (0.3%) for maximum separation of high weight
bands
pUC57 Digest
1) Add to 0.65mL Eppendorf Tube
a. Nano pure H2O

2.7μL
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b. Multicore Buffer

1.5μL

c. BSA

0.1μL

d. SacI

0.3μL

e. NcoI

0.3μL

f. pUC57 vector DNA

10.0μL

2) Place in 37°C water bath for 2-4 hours
3) Heat inactivate NcoI by placing in 65°C water bath for 15.0 min
4) Run on Agarose Gel (0.7%) for separation of low weight bands
pD730 requires a partial digest due to the multiple cut for NcoI in its
sequence (see vector map). Thus the time exposure to NcoI was
varied. pUC57, however, does not have this issue and so the NcoI
exposure is longer to ensure a complete digest. The appropriate
fragment of the vector must be separated from the other bands prior
to ligation, hence the agarose gels were used. These bands are then
cut out of the gel in the next protocol
Isolating DNA from Agarose Gels
Uses MO-BIO’s Ultraclean Gel Spin Kit
1) Cut band from gel and determine weight, less than or equal to
200mg
2) Place in spin filter basket, add three volumes of “Gel Bind”
a. I.e. if gel weighs 0.2g then add 0.6mL “Gel Bind”
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3) Incubate 2 minutes at 55°C water bath. Invert to mix, continue to
incubate at 1 minute intervals until gel is completely melted.
4) Centrifuge 10 seconds at 10,000xg
5) Remove filter, Vortex flow through for 5 seconds
6) Reload vortexed flow through onto fliter
7) Centrifuge 10 seconds at 10,000xg
8) Discard flow through
9) Add 300μL “Gel Wash” Buffer
10)

Centrifuge 10 seconds at 10,000xg

11)

Discard flow through, centrifuge an additional 30 seconds at

10,000xg
12)

Discard flow through, add 50μL “Elution Buffer”.

13)

Centrifuge 30 seconds at 10,000xg. Flow through is desired

DNA
14)

Concentration can be determined using A260 method

SAP’d Vector (this time with calf intestinal alkaline phosphatase)
1) DNA

20μL

2) Nano pure H2O

65μL

3) 10x CiAP buffer

10μL

4) CiAP

5μL

5) Incubate at 37°C 1.0 hour
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6) Purify using Amicon Spin column (see Appendix A)
7) Check A260 to determine concentration
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